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ABSTRACT 
 
Certain subfamilies of zinc finger transcription factors (ZNF-TFs), especially 
those including KRAB or SCAN protein-interaction domains, have evolved rapidly in 
mammals due to repeated rounds of gene duplication, deletion, and divergence. The 
functions of the encoded proteins, and the evolutionary role of their duplication and 
divergence, are not well understood. I have focused on mammalian ZNF subfamilies that 
are rooted by relatively unique, conserved members but that have duplicated to generate 
groups of divergent paralogous transcription factors in primate species. One such family 
is the ZSCAN5 subfamily, represented by a single, conserved founding member, 
ZSCAN5B, and clustered paralogs that arose early in primate history, and this clustered 
subfamily has been the subject of my thesis work. I have shown that three of the primate 
paralogs, ZSCAN5A, B, and D, are expressed in different tissues and cell types while 
ZSCAN5C is not detectably expressed in most tissues. Using chromatin 
immunoprecipitation (ChIP-seq) in human cell lines and mouse placenta tissue, I have 
identified mammalian ZSCAN5B as a protein that binds with high specificity to tRNA 
genes (tDNA) and other polymerase III (Pol III) transcripts including several types of 
transposable elements (TEs). Primate-specific paralogs ZSCAN5A and ZSCAN5D also 
bind tDNAs, although ZSCAN5D preferentially recognizes a subset of TE-derived 
“extra-TFIIIC” or ETC sites.  
I also used siRNA knockdown followed by transcriptome sequencing (RNA-seq) 
to identify biological functions of the dominantly expressed paralog ZSCAN5A and the 
ancestral ZSCAN5B gene. In addition to tDNAs and other Pol III transcripts, I show that 
ZSCAN5A and ZSCAN5B gene knockdown also dysregulates many Pol II genes including 
some that are located near the DNA binding regions. Significant overlap between the 
differentially expressed gene (DEG) sets detected after ZSCAN5A or ZSCAN5B 
knockdown suggested that the two proteins may act cooperatively through their similar 
SCAN domains. The DEG sets thus suggested similar biological functions for ZSCAN5A 
and ZSCAN5B, but also highlighted some potentially distinct activities. In particular, 
based on these data I hypothesize that ZSCAN5B primarily regulates ribosome 
biogenesis and tRNA processing, whereas ZSCAN5A has an especially important role in 
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mitotic progression. Consistent with this latter function, I show that ZSCAN5A as well as 
its human paralogs are cell-cycle regulated with peak expression around the time of 
mitosis. 
To test these hypotheses about gene function, I generated a series of resources 
including both human cell lines and transgenic mice engineered to overexpress or knock 
down ZSCAN5 genes specifically. Focusing on the predicted role of ZSCAN5A in cell 
cycle progression, I showed that ZSCAN5A knockdown dysregulates cell cycle 
progression in cultured human cells, leading to an accumulation of cells in mitotic phase 
and the appearance of aneuploid cells. These data suggest that, either through a cyto-
architectural function, regulation of Pol III transcription, position effects on Pol II genes, 
or a combination of these roles, ZSCAN5A has an essential role in maintenance of 
chromosome integrity in human cells. These data open up many new avenues for future 
exploration. 
Together these data define unexpected functions for a conserved mammalian gene 
and two paralogs found only in primate genomes. The human paralogs have evolved from 
the basic tDNA-binding function of the conserved founder gene, ZSCAN5B, to bind more 
widely to Pol III transcripts and other TFIIIC binding sites and affect the transcription of 
a wider selection of nearby genes. Data presented here indicate that despite being 
duplicated only in primates, ZSCAN5A has been integrated into the control of a very 
ancient process, namely chromosome segregation during mitosis, and plays an important 
role in chromosome integrity. The new tools and resources I have developed provide 
essential tools needed to explore those functions in further depth. 
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CHAPTER 1: 
 
INTRODUCTION 
 
Evolution of Regulatory Networks 
 
 While it is still controversial and vague to define a true meaning of ‘life’, 
scientifically and traditionally, ‘life’ is specifically distinguished by the capacity that it 
can grow, metabolize, respond to stimuli, adapt, and reproduce. This reproductive 
capacity elicits numerous generations of offspring, and each generation offers a new 
opportunity for evolution of form and function. From simple single-cell bacteria to highly 
complex vertebrate mammals, every known living organism on the planet earth follows a 
simple rule known as the “Central dogma of molecular biology”(Crick, 1970; Crick, 
1958). Each organism carries its own genetic material that is transcribed and further 
translated into useful peptides to sustain its viability, and replicated to produce additional 
progeny. Amongst these important processes, an accurate and sophisticated transcription 
of each gene is essential for the successful development and survival of the living 
organism (Jacob and Monod, 1961). This fine control is called “transcriptional 
regulation”.  
 The transcriptional regulation system is principally composed of cis- and trans-
regulatory elements (Davidson 2006). Cis-regulatory elements are typically non-coding 
DNA segments that contain binding sites for transcription factors (TFs) and other 
regulatory proteins that are required to activate and sustain transcription; the well-
characterized examples of these cis-elements are enhancers and promoters (Blackwood 
and Kadonaga, 1998; Pennacchio et al., 2013; Smale and Kadonaga, 2003). Conversely, 
trans-regulatory factors include proteins, RNAs, and other diffusible molecules that 
affect gene expression, primarily by interacting with the cis DNA sites (Gilad et al., 
2008). The basic biochemical function of a TF is firstly, to recognize and bind a short, 
specific string of nucleotides (called a motif) within cis-regulatory regions, and secondly, 
to recruit or bind other proteins relevant to transcriptional regulation; these include other 
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TFs, chromatin remodeling complex components, and the general RNA polymerase 
machinery (Karin, 1990; Latchman, 1997). Thus, the interaction between a TF and a 
specific cis-regulatory element may endow positive or negative changes to the basal 
expression of a target gene (Lee and Young, 2000; Nikolov and Burley, 1997; Roeder, 
1996). 
 Because these systems orchestrate the specification of a particular cell type or 
structure, heritable changes to regulatory networks result in the evolution of animal 
morphology and phenotypic variations across organisms (Carroll et al., 2013; Rubinstein 
and de Souza, 2013). Throughout the course of evolution, as biological systems have 
become more complex, the amount of information devoted to the transcription regulation 
must increase accordingly. Or conversely, it is thought that the expansion and variations 
in regulatory systems may have facilitated the emergence of complex organisms and the 
evolution of multicellularity (Levine and Tjian, 2003).  
 There still is an ongoing debate whether the changes to cis-regulatory elements or 
to trans-regulatory elements have served as the prevalent means by which regulatory 
networks evolve. However, available evidence suggests that evolutionary changes in both 
cis- and trans- components have played important roles. Comparative genomics studies 
have suggested a substantial level of cis-regulatory variation across species, and it has 
long been hypothesized that these changes in cis-regulatory elements are predominantly 
responsible for the changes in regulatory network function (Borneman et al., 2007; 
Bradley et al., 2010; Carroll, 2005; Odom et al., 2007; Prud'homme et al., 2007; Wray, 
2007). Other support for this arises because of the likely negative pleiotropic effects that 
could occur when mutations in protein-coding regions of TFs take place (Carroll, 2005; 
Hsia and McGinnis, 2003). In other words, variation in a transcriptional regulator can 
affect multiple target genes simultaneously and result in widespread detrimental 
ramifications, whereas, a mutation in single a cis-regulatory element will only affect 
changes in the local gene expression pattern (Carroll, 2005; Davidson and Erwin, 2006; 
Doebley and Lukens, 1998; Hsia and McGinnis, 2003; Wittkopp, 2005; Wray, 2007). 
 However, recent studies have accumulated significant evidence that variations in 
trans-regulatory proteins may be more common than it was originally appreciated (Brem 
et al., 2002; Bustamante et al., 2005; Yvert et al., 2003). Altering the expression, post-
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translational modification, and molecular interactions of regulatory proteins have been 
suggested as strategies for promoting regulatory network evolution (Grove et al., 2009; 
Lynch et al., 2011; Reece-Hoyes et al., 2013; Sayou et al., 2014).  
 
Expansion of TFs and C2H2 zinc finger proteins during evolution 
 
 At the base of the metazoan lineage, many TF families have undergone a series of 
duplications and divergence resulting in numerous homologs, which provide a valuable 
source of novel material for building extended gene regulatory networks (Degnan et al., 
2009; Pérez et al., 2014; Teichmann and Babu, 2004).  
 There are two primary ways in which new TF homologs can be generated. When 
species diverge from a common ancestor, each initially retains nearly identical sets of 
TFs, or one-to-one orthologs. Until a novel regulatory mechanism is invented, the 
orthologous proteins tend to serve the same function in each species as they did in the 
ancestor. These newly generated orthologs exist under a great amount of evolutionary 
constraint to remain conserved. On the other hand, TFs generated by gene duplication 
events, which create new paralogs, have ample freedom to evolve (Hoekstra and Coyne, 
2007). While most gene duplicates are simply lost, others undertake some of the ancient 
roles of the original TF by reducing the load on each copy and giving each copy more 
plasticity to change. This subdividing is known as “subfunctionalization” (Force et al., 
1999). Ultimately, if one copy retains all of the ancestral roles, the other paralogs will 
have essentially no constraint and can acquire a new function, or neofunctionalize 
(Reece-Hoyes et al., 2013). In this way, generation of parallels results in modularity 
within a TF family, because each parallel endows the others with greater freedom to 
change. 
 Of the various families of TFs, the C2H2 zinc finger (ZNF) TF gene family is by far 
the largest, and the most evolutionarily divergent (Huntley et al., 2006; Lander et al., 
2001; Urrutia, 2003; Venter et al., 2001). ZNF genes encode one of the most abundant 
protein families in all eukaryotic species, being found, for example, in approximately 2% 
of all human genes (Lander et al., 2001). Several subfamilies of this large ZNF family 
have evolved through massive lineage-specific expansions, thus providing a putative 
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source for gene regulatory change (Huntley et al., 2006; Liu et al., 2014; Nowick et al., 
2011; Nowick and Stubbs, 2010; Stubbs et al., 2011) (Fig. 1.1).  
 The modular structure of the ZNF genes and proteins may be especially suited to 
modifications that lead to evolutionary change. ZNF TFs contain at least 3, and as many 
as 40 discrete C2H2 zinc finger motifs that function cooperatively, although each 
contributes distinctly and additively to DNA binding properties of the protein (Huntley et 
al., 2006; Iuchi, 2001). Within each motif, conserved cysteine and histidine amino acids 
coordinate binding to a single zinc ion; zinc binding allows the finger to fold into a 
compact structure containing a beta-turn that includes the conserved cysteines and an 
alpha-helix that includes the conserved histidines (Frankel et al., 1987; Klug and 
Schwabe, 1995; Pavletich and Pabo, 1991; Stubbs et al., 2011) (Fig. 1.2A). Even though 
there is variation between some amino acid positions that compose individual fingers, 
C2H2 motifs are distinguished by the highly conserved, repetitive amino acid pattern 
[TGEKP(Y/F)] that links each finger together and other relatively conserved residues 
within the structure (Bellefroid et al., 1989). Each individual finger recognizes 3 base 
pairs of DNA through interactions between the α-helix region and the DNA site, in such a 
way that the array of tandem fingers winds around the major groove of the DNA 
molecule in a highly sequence-specific manner (Pavletich and Pabo, 1991) (Fig. 1.2B). 
Within each finger, four specific DNA-contacting residues, at amino acid positions -1, 
+2, +3 and +6 of the alpha helix, are primarily responsible for contacting DNA (Klug, 
2010; Wolfe et al., 2000); we have referred to the pattern of four DNA-contacting amino 
acids in each zinc finger as a protein’s “fingerprint”. These fingerprint patterns can be 
compared across species to determine the conservation of a ZNF-DNA binding (Stubbs et 
al., 2011). 
 
History and known functions of SCAN-domain ZNF genes 
 
 Usually found on the N-terminus of the C2H2 zinc finger elements in some of the 
transcription factors, a series of extended sequence motifs are associated to help define 
these regulators. These structural modules are known to regulate subcellular localization, 
DNA binding, and gene expression by controlling selective recruitment of the TFs or 
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other chromosome remodeling proteins. These associated modules include the Krüppel-
associated box (KRAB) (Bellefroid et al., 1991), the poxvirus and zinc finger (POZ) 
domain (Bardwell and Treisman, 1994), which is also known as the BTB domain (Broad-
Complex, Tramtrack, and Bric-a-brac) (Albagli et al., 1995), and the SCAN domain 
(Williams et al., 1995). These domains define subgroups within the C2H2 family and 
may provide insights into the functions of the members of this large family of zinc finger 
TFs.  
 The SCAN domain, which is also known as the leucine rich region, is a highly 
conserved 84-residue motif that is found near the N-terminus of a subfamily of C2H2 
zinc finger proteins (Pengue et al., 1994). The SCAN domain was originally identified in 
ZNF174 (Williams et al., 1995). The name was based on the first letters found in some of 
the founding members of the family (SRE-ZBP, Ctfin51, AW-1 (ZNF174), and Number 
18). Studies utilizing either mammalian or yeast two-hybrid systems demonstrated the 
protein interaction function of the SCAN domain, mediating self-association or selective 
association with other proteins (Sander et al., 2000; Schumacher et al., 2000; Williams et 
al., 1995). However, unlike the KRAB and BTB/POZ domains, no apparent 
transcriptional activation or repression properties were detected for SCAN domains 
(Sander et al., 2000; Williams et al., 1999). Affinity purified SCAN domains of ZNF174 
exhibited stable homodimerization with high melting temperature in vitro (Stone et al., 
2002). In view of the regulatory repertoire, TF dimerization can expand the selectivity of 
protein-DNA interactions, by increasing the length of the DNA motif that interacts with 
the proteins as they bind to DNA side-by-side; furthermore, since most TFs can dimerize 
with several others in different combinations, this process can also generate increased 
diversity of genomic binding sites from a relatively small number of proteins (Lamb and 
McKnight, 1991). Indeed, the SCAN domains found in lower vertebrates are not 
associated with C2H2 DNA-binding motifs, and it is thought that the rapid and lineage-
specific expansion of SCAN-ZNF proteins once this combination arose may have 
contributed to the diversity seen in higher vertebrates (Sander et al., 2003). 
 At present, only a few functional descriptions of SCAN-ZNFs have been reported. 
Zscan10 (Zfp206), a SCAN-ZNF with 14 tandem C2H2 ZNFs, is known to maintain 
embryonic stem cell (ESC) pluripotency by interacting with the established pluripotency 
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marker Sox2 and Oct4 (Wang et al., 2007). Kraus and colleagues have suggested a role 
for Zscan10 in maintaining the progenitor cell subpopulation and/or impacting fate 
choice decisions, which are based on the findings that Zscan10 homozygous null mice 
exhibited reduced weight, mild hypoplasia in the spleen, heart and long bones and 
phenocopy an eye malformation described for Sox2 hypomorphs (Kraus et al., 2014). 
Another SCAN-ZNF protein, Zscan4, has also been linked to early steps in stem cell 
differentiation. Zscan4 gene expression was shown to reactivate early embryonic genes, 
enhance the efficiency of generating induced pluripotent stem cell (iPSC), and 
functionally replace Myc, which increases cell proliferation and suppresses genome 
stability (Hirata et al., 2012; Nakagawa et al., 2010). 
 
Long-range gene regulation and RNA polymerase III transcription system 
 
 Conventional concepts of gene regulation involve one or more TFs that bind to cis-
regulatory elements, usually a promoter, to either activate or repress the nearby gene (Lee 
and Young, 2000; Nikolov and Burley, 1997; Roeder, 1996). However, studies over the 
last twenty years have suggested additional models, in which gene regulation can be 
controlled by regulatory elements located some distance from the transcription start site 
(TSS) (Blackwood and Kadonaga, 1998; Pennacchio et al., 2013; Smale and Kadonaga, 
2003). These elements have been proposed to interact with gene promoters through 
chromatin loops, organized by proteins that mediate these higher order chromatin 
configurations and nuclear architectures by binding to specific DNA sites (Clelland and 
Schultz, 2010; Conesa et al., 2005; Simms et al., 2008). There are very likely many 
different mechanisms that form and mediate these structures, and the classes of proteins 
involved in these processes are just beginning to be understood. However, one system of 
cis- and trans- elements that mediate chromatin architecture is particularly ancient, being 
found in all eukaryotic genomes examined to date (Pascali and Teichmann, 2013). This 
system involves RNA polymerase III (Pol III) transcription units and the Pol III TF, 
TFIIIC. 
 Among the three eukaryotic DNA-dependent transcription complexes, RNA Pol III 
and was discovered as the complex responsible for production of transfer RNA (tRNA) 
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and a limited number of other small RNAs including the small 5S ribosomal RNA 
(rRNA), the 7SL RNA, U6 spliceosomal RNA (Geiduschek and Kassavetis, 2001; Huang 
and Maraia, 2001; Paule and White, 2000). Mammalian RNA Pol III genes are 
transcribed from three distinct types of promoters; type 1 (5S genes) and type 2 (tRNAs 
and viral associated RNA) promoters are internal to the genes, while type 3 (U6, RNase 
P, RNase MRP genes) promoters are located upstream of TSS (Dieci et al., 2007; Orioli 
et al., 2012). Type 1 and 2 promoters include the A and the B box motifs, which recruit 
the transcription factor TFIIIC. The B box has been shown to primarily recruit TFIIIC 
and B Box sequences with robust TFIIIC binding also occur at sites that are not actively 
transcribed by Pol III. These sites, known as ‘Extra-TFIIIC’ (ETCs) sites exist in every 
species that have been examined and have been referred to as ‘Chromosome Organizing 
Clamps’ (COCs) in yeast (Moqtaderi and Struhl, 2004; Noma et al., 2006).  
 Some of these ETC sites are very likely created by transposable elements. Indeed 
many of the most common repetitive elements in higher eukaryote genomes are derived 
from Pol III genes. For example, small interspersed nuclear elements (SINEs), which 
represent up to 11% of the entire human genome (Cordaux and Batzer, 2009), have been 
suggested to originate from 7SL RNA genes, and a more ancient element, called MIR, is 
thought to originate from tRNA genes (tDNAs) (Jurka et al., 1995; Silva et al., 2003; 
Smit and Riggs, 1995). Many of these SINE elements retain a recognizable B Box motif 
and TFIIIC binding, and a few of these elements are actively transcribed by Pol III 
(Aleman et al., 2000; Berger and Strub, 2011; Cordaux and Batzer, 2009; Shaikh et al., 
1997).  
 Pol III transcription is known to be critical for cell survival, but in addition to its 
canonical tRNA synthesis activity, recent studies demonstrate other crucial roles in 
various nuclear processes, including effects on nucleosome positioning, global genome 
and subnuclear organization, and direct effects on RNA pol II transcription (Clelland and 
Schultz, 2010; Conesa et al., 2005; Simms et al., 2008). In fact, tDNAs have been shown 
to act as insulators in both yeast and human cells (Ebersole et al., 2011; Hull et al., 1994; 
Kendall et al., 2000; Kinsey and Sandmeyer, 1991; Raab et al., 2012). For example, 
tRNA gene-mediated silencing (tgm) and other effects on nearby gene expression may 
involve an enhancer-blocking insulator activity facilitated by chromosome loop 
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formation. In yeast, tgm silencing was first discovered when it was shown that active 
transcription of tRNA genes represses Pol II transcription from nearby promoters (Bolton 
and Boeke, 2003; Hull et al., 1994; Kendall et al., 2000; Kinsey and Sandmeyer, 1991). 
Also in S. cerevisiae, widely distributed tRNA genes have been shown to cluster in the 
proximity of 5S RNA genes in the nucleolus (Thompson et al., 2003; Wang et al., 2005) 
and this unique tDNA clustering was found crucial for the inhibition of Pol II 
transcription (Haeusler et al., 2008; Wang et al., 2005). The nucleolar relocation of tDNA 
clusters results in the formation of chromatin loops and this is facilitated by cooperative 
interactions between TFIIIC and condensin (D'Ambrosio et al., 2008; Haeusler et al., 
2008; Wang et al., 2005).  
 However, the first type of insulator function assigned to tDNA was heterochromatin 
barrier activity. Specifically, a tRNAThr gene located near the centromere was shown to 
restrict the spread of heterochromatin in S. cerevisiae (Donze et al., 1999; Donze and 
Kamakaka, 2001). Even though, mechanisms for establishing barrier activity vary in 
different tDNAs, it has been proposed that TFIIIB, which is recruited by and after 
TFIIIC, attracts histone acetyltransferase and other chromatin remodeling complexes, 
such as ISW2, to demarcate the region (Bachman et al., 2005; Donze and Kamakaka, 
2001; Gelbart et al., 2005). While most work has focused on the yeasts including S. 
cerevisiae and S. pombe, several lines of evidence suggested that mammalian Pol III 
complexes exert similar functions, but with a few potentially important differences (Van 
Bortle and Corces, 2012). 
 In mammalian cells, the protein encoded by the proto-oncogene c-MYC was found 
to activate Pol III transcription not only by directly interacting with TFIIIB (Gomez-
Roman et al., 2003), but also by recruiting chromatin modifying complexes, including 
histone acetyltransferase (KAT2A) (Flinn et al., 2002) and TRRAP (Kenneth et al., 2007) 
to mobilize histones around tDNA regions to facilitate TFIIIC binding. In turn, TFIIIC 
appears to introduce active histone modifications when bound at ETC sites near Pol II 
genes, but the opposite at the transcribed Pol III genes (Barski et al., 2010; Jin et al., 
2009; Oler et al., 2010). Moqtaderi and colleagues exploited ChIP-seq in human cells to 
also discover that 1) A/B box regions are free of nucleosomes; 2) most ETCs were 
located <1 kb of Pol II promoters; 3) TFIIIC, but not Pol III, binds to ETC and co-
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localizes with CCCTC binding factor (CTCF) at those sites, and 4) tDNAs and ETC sites 
interact with each other preferentially across long-range chromatin loops (Moqtaderi et 
al., 2010). These authors also showed, using a reporter assay system that tDNA 
sequences could function as enhancer-blocking insulators in cultured mammalian cells 
(Moqtaderi et al., 2010). The link between TFIIIC and CTCF binding is of particular 
interest, since most mammalian insulators bind CTCF and CTCF-cohesin complex is 
required for enhancer-blocking insulation in vertebrates (Bell and Felsenfeld, 1999; 
Filippova et al., 2005; Magdinier et al., 2004; Mishiro et al., 2009; Phillips and Corces, 
2009; Wendt et al., 2008).  
 Interestingly, SINEs, which make up a substantial fraction of the mammalian ETC 
repertoire, have also been linked to enhancer-blocking insulation (Lunyak et al., 2007; 
Román et al., 2011). Alu elements are often associated with cohesin and CTCF 
homodimer or multimers to result in the formation of interchromosomal loops (Hakimi et 
al., 2002; Parelho et al., 2008; Wendt et al., 2008; Wood et al., 2010). Alu RNAs are 
normally repressed of their expression by nucleosome positioning and DNA methylation 
(Englander et al., 1993; Kim et al., 2001; Li et al., 2000; Liu et al., 1994; Liu and 
Schmid, 1993; Russanova et al., 1995)  
 In this context, it is interesting to note that there has been approximately 250-fold 
expansion in the size of genome from yeast to human, yet that the number of tDNAs has 
barely increased (274 in yeast versus approximately 500 in the human genome) (Canella 
et al., 2010; Dittmar et al., 2006; Harismendy et al., 2003; Moqtaderi and Struhl, 2004; 
Roberts et al., 2003). The numbers of tDNAs is probably constrained to some degree by 
their participation in other cellular functions. Pascali has suggested that the Pol III-
derived repetitive elements such as SINEs may serve to compensate for the relatively low 
density of tDNAs in mammals, and that they may play a significant role in organizing 
three-dimensional structure of the genome in higher eukaryotes (Pascali and Teichmann, 
2013). 
 Several lines of evidence now support this interesting hypothesis. If it is correct, it 
seems likely that the genomes of higher eukaryotes must also have developed novel 
mechanisms for regulating these elements, and their chromatin-organizing functions.  
Given their evolutionary history, one might predict that certain members of the KRAB- 
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or SCAN-ZNF families might be involved in these novel and species-diverse functions. 
Indeed, our studies suggest a role for one SCAN-ZNF subfamily, which is the primary 
subject of this thesis. 
 
Zscan5b and the ZSCAN5 family  
 
 The murine Zscan5b protein contains five C2H2 zinc-finger domains (sequence-
specific DNA binding motif) and SCAN domain (effector) at its N-terminus (Fig. 1.3A). 
While murine Zscan5b stands out as a single, highly conserved gene in mouse and other 
mammalian genomes, it has recently duplicated to generate a cluster of four primate-
specific daughter genes, the ZSCAN5 family, ZSCAN5A/B/C/D (Huntley et al., 2006) 
(Fig. 1.3B). These human orthologs have been recently annotated and are shown to 
encode full-length SCAN-ZNF proteins. Although murine Zscan5b and human 
ZSCAN5B are quite divergent, sharing only 70% amino acid identity in their finger 
domains, these proteins share almost identical amino acid sequences in the DNA binding 
residues (-1, +2, +3, +6) of each finger suggesting that they may recognize similar DNA 
binding sites and targets (Fig. 1.3C). However, the sequence differences among the three 
other human paralogs suggest that they may bind to related but distinct DNA binding 
motifs. While, mouse, marmoset and human ZSCAN5B proteins share almost identical 
fingerprints, the three primate-specific paralogs have diverged from the ancestral gene in 
fingerprint patterns (Fig. 1.3C). After an initial phase of divergence in early primate 
history, these patterns have been very well conserved. In contrast to the zinc fingers, the 
SCAN domains of the four human ZSCAN5 family members are nearly identical (95-
98% identity between members; not shown). Given that the SCAN domains mediate 
protein dimer formation (Sander et al., 2000; Schumacher et al., 2000; Williams et al., 
1995), ZSCAN5 family members may interact as heterodimers, cooperating in different 
combinatorial patterns in the tissues and cell types in which they are co-expressed.  
 In this dissertation, I attempt to address questions such as: What kinds of functions, 
and which pathways, have acquired novel regulatory functions through duplicative 
expansion of the SCAN-ZNF transcription factor families? Do the novel proteins take on 
properties that are distinct from conserved parental genes, or do they “subfunctionalize”, 
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taking on a subset of roles that were originally carried out by the mammalian ancestors?  
 Chapter 2 covers the expression profile, identification, and validation of DNA-
binding sites of ZSCAN5 family. The human paralogs have diverged from ZSCAN5B in 
both zinc-finger structure and expression patterns, but share expression in dividing cell 
populations with a distinct peak around the time of mitosis. Our data have revealed that 
tDNAs are the preferred binding sites for mouse and human ZSCAN5B as well as 
ZSCAN5A; paralog ZSCAN5D also binds similar loci but preferential binding to MIR, 
SINE, and LINE2 elements including a previously described novel ETC motif 
(Moqtaderi et al., 2010). We also examine the differential expression of nearby Pol II 
genes to understand the regulatory functions of ZSCAN5 family.  
 Chapter 3 further investigates the biological functions of ZSCAN5s with regard to 
their roles in the cell cycle progression using overexpression and knockdown transgenic 
human cell lines (in vitro) and transgenic mice (in vivo). In addition, to comprehend the 
mechanisms of ZSCAN5 paralogs, we have determined their cellular localization during 
specific cell cycle stages and examine putative combinatorial interactions between the 
paralogs and with other predicted binding partners. 
 Chapter 4 describes the generation of some essential tools, including expression 
constructs and two sets of transgenic mouse lines developed to address the root biological 
functions of the ZSCAN5 family through analysis of the unique mouse family member, 
Zscan5b. 
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FIGURES 
Figure 1.1. 
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Figure 1.1. (cont.) Phylogenetic distribution of C2H2 ZNF protein families  
The distribution and number of poly-C2H2 ZNF proteins in different families is shown in 
this phylogeny of all eukaryotic model systems. The gain and loss of genes over 
evolution can be seen along the tree for all poly-C2H2 (red) BTB/POZ (orange), ZAD 
(green), KRAB (blue), and SCAN (purple) KZNF families. The numbers of genes in each 
family are shown in the accompanying table. Information was compiled from the PFAM 
Database (Finn et al. 2010), unless otherwise noted as coming from [1] (Riechmann et al. 
2000),[2] (Materna et al. 2006), [3] (Chung et al. 2002), [4] (Huntley et al. 2006) or [5] 
(Emerson & Thomas 2009). Modified from Stubbs, Sun and Caetano-Anolles, 2011 
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Figure 1.2. 
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Figure 1.2. (cont.) (A) Structure of tandem C2H2 DNA-binding motif  
Individual zinc ions interact with paired cysteine and histidine residues, stabilizing two β-
sheets and one α-helix (as indicated by the areas within the dotted lines) into the 
recognizable “finger” structure shown here, with the latter containing the DNA-binding 
interface as indicated in the figure at the –1, +2, +3, and +6 positions relative to the helix. 
The structure of a finger sequence motif is represented, with X denoting an amino acid 
residue of any type with the subscript representing the number (ie. X2-4 represents a chain 
of between 2 and 4 non-specified amino acid residues). The consensus sequence – 
TGEKP(Y/F) – is a highly conserved “H/C link” region between consecutive fingers.  
(B), (C) DNA binding properties of tandem C2H2-ZNF domains  
The α-helices of C2H2-ZNF motifs contain amino acid residues that bind to DNA 
nucleotides at the -1, +2, +3, and +6 sites represented as white dots on the helices of a set 
of tandem zinc fingers. The relationship between fingers and nucleotides is not one-to-
one, as the amino acid at the +2 position will interact with the nucleotide complementary 
to the neighboring finger’s +6 binding site. In this fashion, fingers wind around the major 
groove of the DNA molecule. (Stubbs et al. 2011) 
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Figure 1.3. 
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Figure 1.3. (cont.) 
 (A) Structure of Zscan5b protein  
A SCAN (protein interaction motif) domain tethered to N-terminus to five tandem C2H2 
zinc finger DNA binding domains. 
 (B) Gene duplication of Zscan5b  
While mouse Zfp787, Zfp444, Galp have 1:1 orthologs in human chromosome 19, 
Zscan5b has been duplicated to create 4 primate-specific duplicates, ZSCAN5A/B/C/D. 
(C) ZSCAN5 family fingerprints comparison  
Amino acids that are positioned at -1, 3, 6 are responsible for binding to specific DNA 
sequences. Mouse, marmoset and human ZSCAN5B proteins share almost identical -
fingerprints indicating that they bind to very similar DNA motifs. In contrast, the three 
primate-specific paralogs have diverged significantly from the parental gene and from 
each other in fingerprint patterns after duplication. 
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CHAPTER 2: 
 
ZSCAN5B AND ITS PRIMATE-SPECIFIC PARALOGS BIND RNA 
POLYMERASE III GENES AND EXTRA-TFIIIC (ETC) SITES IN 
MAMMALIAN CELLS 
Younguk Sun1,2, Huimin Zhang1,2, Majid Kazemian1,3,6, Joseph M. Troy1,4, Christopher 
Seward1,2, Xiaochen Lu1,2, Saurabh Sinha1,3, and Lisa Stubbs1,2,4,5 
 
ABSTRACT 
 
Particularly in the context of differentiation and development, the importance of 
three-dimensional chromatin architecture on gene regulation is becoming increasingly 
clear.  The most ancient known mechanism of chromatin organization involves TFIIIC, a 
transcription factor (TF) that recruits RNA polymerase III (Pol III) for transcription of 
tRNA and other types of non-coding RNA genes. From yeast to mammals, TFIIIC also 
binds to scattered “extra-TFIIIC” (ETC) loci, serving to tether those loci together as 
anchors of chromatin loops. TFIIIC activities are modulated by MAF, MYC, and other 
TF proteins, many of which are likely unknown. Here we identify the ZSCAN5 TF 
family - including mammalian ZSCAN5B and its primate-specific paralogs - as proteins 
that occupy mammalian Pol III promoters and ETC sites. ZSCAN5B binds with high 
specificity to a subset of conserved tRNA genes (tDNA) in human and mouse chromatin, 
and modulates the expression of those and other Pol III genes. Primate-specific 
ZSCAN5A and ZSCAN5D also bind tDNA, although ZSCAN5D preferentially localizes 
to MIR SINE- and LINE2-associated ETC sites. ZSCAN5A and ZSCAN5B knockdown 
experiments indicate important and cooperative roles in regulating tRNA and rRNA 
processing, cell cycle progression and differentiation in a variety of tissues. Together 
these data indicate that ZSCAN5 protein binding directly regulates levels of Pol III gene 
transcription, thereby exerting position effects on nearby Pol II genes; ultimately, this 
activity influences cell cycle progression and differentiation during development and in 
adult tissues.  
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INTRODUCTION 
 
In traditional models of gene regulation, transcription factors (TFs) interact 
locally to enhance or block RNA polymerase recruitment to nearby promoters. However, 
long-range interactions enabled by chromatin looping are increasingly being recognized 
for essential regulatory roles (Levine et al., 2014). The most ancient known mechanism 
of chromatin loop organization is dependent on TFIIIC, a deeply conserved TF that 
recruits TFIIIB, TFIIIA and RNA polymerase III (Pol III) to promoters of tRNA genes 
(tDNAs) and other types of Pol III transcripts (Pascali and Teichmann, 2013). Through 
association with TFIIIC, tDNAs and other binding sites cluster within the nucleus to 
serve as key determinants of three-dimensional genomic architecture and exert chromatin 
barrier, insulator and other regulatory functions. These functions appear to be remarkably 
well conserved across eukarya, as confirmed by studies in yeast, insects, and mammals 
(Crepaldi et al., 2013; Hiraga et al., 2012; Van Bortle et al., 2014; Wang et al., 2014).   
Most vertebrate tDNAs are organized in genomic clusters at homologous, 
syntenic positions, thus providing a stable and conserved framework for chromatin 
structure (Van Bortle and Corces, 2012). However not all TFIIIC binding sites are so 
highly conserved. In particular, extra-TFIIIC, or ETC sites, also called “chromatin 
organizing clamps” in yeast, interact with each other and with tDNA to influence 
chromatin architecture (Noma et al., 2006; Raab et al., 2012). In mammals, Pol III and 
TFIIIC binding sites include SINE repeats, transposable elements including MIRs, ALUs 
and other SINE subfamilies that were originally derived from Pol III transcription units 
(Cordaux and Batzer, 2009). These lineage-specific transposable elements (TEs) greatly 
outnumber the evolutionarily more stable tDNA sites in mammalian genomes. 
Furthermore, the expression of individual tRNA genes varies according to cell 
type, cellular states, tissues and developmental stages (Canella et al., 2012; Canella et al., 
2010; Dittmar et al., 2006; Schmitt et al., 2014; Stutz et al., 1989). With or without 
transcription, TFIIIC binding also varies at tDNAs and at ETC sites (Barski et al., 2010; 
Canella et al., 2010; Moqtaderi et al., 2010; Raha et al., 2010; Schmitt et al., 2014).   
TFIIIC, TFIIIB and Pol III recruitment steps are modulated by interactions with 
transcription factors including MAF1, MYC, RB1, P53, and very likely, many other 
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unknown TF proteins (Felton-Edkins et al., 2003; Hiraga et al., 2012; Oler et al., 2010; 
Raha et al., 2010). The influence of these TFs on tRNA expression has direct 
developmental consequences (Rideout et al., 2012) as well as indirect effects on 
transcription of nearby Pol II genes (Kinsey and Sandmeyer, 1991; Lee et al., 2015; 
Moqtaderi et al., 2010; Wang et al., 2014). TFIIIC recruitment to tDNAs and ETCs also 
influences nuclear clustering and thus likely, the selection of alternative anchors for 
chromatin loops (Kirkland et al., 2013; Lee et al., 2015; Raab et al., 2012; Van Bortle and 
Corces, 2012).   
Here we report the DNA-binding functions of ZSCAN5B, a protein encoded by a 
SCAN domain-containing zinc finger (SCAN-ZNF) gene that is unique in most eutherian 
species but was duplicated to generate three paralogs in early primate lineages, two of 
which we also investigate in this study. The paralogs have diverged from ZSCAN5B in 
both zinc-finger structure and expression patterns but overlap in several types of cells and 
tissues. Chromatin immunoprecipitation followed by deep sequencing (ChIP-seq) 
revealed that tDNA sequences are the strongly preferred binding sites for mouse and 
human ZSCAN5B and also for human ZSCAN5A; paralog ZSCAN5D also bind tDNAs, 
but favors binding to MIR SINE and LINE2 elements including a previously identified 
ETC-related motif (Moqtaderi et al., 2010). ZSCAN5A and ZSCAN5B gene knockdown 
resulted in higher expression of bound Pol III transcripts and dysregulation of nearby 
polymerase II (Pol II)-expressed genes, enriched in functions including the regulation of 
tRNA and rRNA processing, cell-fate decisions, and control of mitosis. Based on these 
data, we conjecture that ZSCAN5B evolved in eutherians to directly modulate the 
expression and interaction of bound Pol III transcription units, and that ZSCAN5A and 
ZSCAN5D evolved in primates to extend this negative regulatory activity to include a 
wider range of TFIIIC binding sites, including MIR and L2 repeat-associated ETCs. 
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RESULTS 
 
The ZSCAN5 family arose by duplication of conserved Zscan5b in early 
primate history 
 
Zscan5b is a unique gene in mouse and most other eutherian genomes, but 
primate genomes contain four very closely related gene copies, annotated as human 
ZSCAN5A, ZSCAN5B, ZSCAN5C and ZSCAN5D (Harrow et al., 2006). Human 
ZSCAN5B is clearly the ortholog of the single mouse gene as confirmed by overall 
sequence similarity as well as the alignment of the DNA-binding amino acids of each 
zinc finger (corresponding to amino acids -1, 2, 3, and 6 relative to the alpha-helix) 
(Berg, 1992; Pavletich and Pabo, 1991; Wolfe et al., 2001) (Fig. 2.1). For simplicity, as 
we have in a recent paper (Liu et al., 2014), we will refer to this pattern of DNA-binding 
amino acid quadruplets as a protein’s “fingerprint” henceforth.  
Mouse, marmoset and human ZSCAN5B proteins share almost identical 
fingerprints, but the three primate-specific paralogs have diverged from the parental gene 
in fingerprint patterns. After an initial phase of divergence in early primate history, these 
patterns have been very well conserved (Fig. 2.1). In contrast to the zinc fingers, the 
SCAN domains of the four human ZSCAN5 family members are nearly identical (95-
98% identity between members; not shown). Since SCAN mediates protein dimer 
formation (Collins et al., 2001; Schumacher et al., 2000), this suggests that ZSCAN5 
family members should interact as heterodimers, cooperating in different combinatorial 
patterns in tissues and cell types where they are co-expressed. 
We found orthologs of all four human genes in the marmoset genome but 
identified only a unique ZSCAN5B-related copy in other eutherian genomes and in 
genomes of more primitive primates such as Galago (not shown). Available evidence 
therefore indicates that ZSCAN5A, ZSCAN5C, and ZSCAN5D genes are present only in 
new world monkeys and later-evolving primates. 
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ZSCAN5 paralogs display overlapping but unique patterns of 
expression  
 
Overlapping but distinct patterns of tissue-specific expression in human tissues  
Publicly available data indicated that both human and mouse ZSCAN5-family 
genes are expressed at high levels in testis but at very low levels in most other adult 
tissues. To further examine expression profiles of ZSCAN5 family members, we used 
quantitative reverse transcript PCR (qRT-PCR) to measure transcript levels of the unique 
mouse Zscan5b and all four human ZSCAN5 genes in panels of RNA derived from adult 
and embryonic tissues (Fig. 2.2A). ZSCAN5C transcripts were not detected, or were 
detected near background levels, in every tissue we tested (not shown). As expected, 
mouse Zscan5b and all three expressed human paralogs were detected at highest levels in 
adult testis. In adult mouse, we found the second highest levels of Zscan5b transcript in 
thymus, fetal liver and placenta with lower levels of expression in brain, lung, and 
skeletal muscle. Across a similar panel of tissues, the human ZSCAN5 paralogs were 
expressed in patterns that differed from that of the mouse gene; ZSCAN5A and ZSCAN5B 
were similarly expressed whereas ZSCAN5D was the most distinct. ZSCAN5A transcripts 
were detected robustly in most tissues, and at much higher absolute levels than any of the 
other primate paralogs. Therefore, the human duplicates have acquired distinct features of 
gene expression – either in terms of tissue-specific patterns or overall levels of expression 
– compared to each other and compared to the unique mouse gene. 
 
Mouse and human ZSCAN5B are expressed in populations of actively dividing cells   
To identify cell type-specific expression patterns for the conserved paralog in 
vivo, we developed probes for in situ hybridization (ISH) from the unique 3’-untranslated 
(3’UTR) regions of the mouse and human ZSCAN5B genes. For mouse, we hybridized 
probes to sagittal section of whole embryos taken at 14.5 days post-coitum (E14.5), 
E16.5 and E18.5; for human, we examined paraffin sections of a selection of adult tissues 
on a tissue array. Mouse Zscan5b displayed highest expression in E14.5 heart (Fig. 2.3A, 
2.3C), alveoli of the developing lungs, spinal cord and forebrain (Fig. 2.3A, 2.3B). Heart 
and lung expression was diminished but expression remained particularly high in the 
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olfactory bulb (Fig. 2.3D) and thymus (Fig. 2.3E) at E16.5. By E18.5, expression was 
high in developing skeletal muscle and skin (Fig. 2.3F) and cartilage and lower level in 
bone in the vertebral column (Fig. 2.3G), and in forebrain as well as the intestinal 
epithelia (not shown). In human tissues, ZSCAN5B was also detected in adult skin (Fig. 
2.3H), epithelial cells in the small intestine (Fig. 2.3I), testicular spermatocytes (Fig. 
2.3J), lung epithelia (Fig. 2.3K), and bone marrow (Fig. 2.3L); thymocytes were also 
strongly positive for human ZSCAN5B, while tissue cores taken from several adult brain 
regions were not (not shown). In general, human adult gene expression was highest in 
tissues and cell types with high levels of cellular turnover and cell division. Interestingly, 
despite qPCR data suggesting different patterns of overall tissue-specific expression (Fig. 
2.2A), the cell types and tissues that express Zscan5b in mouse embryos overlap 
considerably with those that display high levels of human ZSCAN5B in adults. 
 
Gene knockdown experiments reveal clues to shared and unique cellular functions 
Testing RNA from a panel of human cell lines with qRT-PCR confirmed the high 
and virtually ubiquitous expression of ZSCAN5A in cultured cells. However, very few 
cell lines also expressed ZSCAN5B or ZSCAN5D (not shown). With the goal of 
examining paralog function in the same cellular context, and we identified two lines – 
BeWo, a trophoblast-like cell line derived from choriocarcinoma, and HEK-293, derived 
from human embryonic kidney but with neuronal characteristics (Shaw et al., 2002) – in 
which all three paralogs were expressed, and focused further on experiments with those 
cell lines.  
Since transfection is particularly efficient for HEK-293 cells, we used this cell 
line for siRNA knockdown experiments. We tested a number of independent siRNA 
designs, both commercially available and custom, for each gene to assess efficiency and 
specificity of paralog knockdown. Most siRNA designs displayed off-target effects 
significantly affecting at least two of the ZSCAN5 genes under conditions we tested (not 
shown). However, two of the siRNA reagents (hereafter called si4 and si5) knocked 
down levels of ZSCAN5A relatively efficiently, with lesser effect on ZSCAN5D but 
marginal levels of knockdown (si5) or even over-expression (si4) for ZSCAN5B. 
Additionally, we found one siRNA design that knocked down ZSCAN5B transcripts quite 
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well and specifically (si1). We identified one siRNA design (si2) that allowed a 
reasonable degree of ZSCAN5D knockdown without reducing levels of either of the other 
two ZSCAN5 genes, but treatment with si2 increased ZSCAN5B transcripts levels 
significantly in HEK-293 cells (Fig. 2.4A, Table A.1). Unlike ZSCAN5A, we could not 
find a second siRNA that knocked down ZSCAN5D without significantly effecting the 
levels of other genes, and this issue complicated further functional analysis for this 
paralog.   
We analyzed RNA from cells treated with si1, si4, si5, and a scrambled control 
using RNA-seq to identify differentially expressed genes (DEGs). Since two siRNA 
designs could be tested independently, the ZSCAN5A siRNA analysis yielded the most 
robust and reliable DEG set (363 genes detected with adjusted P > 0.05, fold change > 
1.5; Table A.2). Analyzing these DEGs with the DAVID functional analysis program 
(Huang et al. 2009) revealed very high enrichment for specific functional categories in 
the up- and down-regulated genes (Table 2.1). Notably, genes up-regulated after 
ZSCAN5A knockdown (e.g. negatively regulated by ZSCAN5A) included regulators of 
ribosome biogenesis and cell cycle regulators especially proteins controlling spindle 
attachment, chromosome segregation and the metaphase/anaphase transition. Down-
regulated DEGs (positively regulated by ZSCAN5A) were significantly enriched for 
functions including transcriptional regulation, cell adhesion, and cell-fate commitment in 
a variety of tissues.  
Genes differentially expressed after human ZSCAN5B knockdown displayed 
significant levels of overlap with ZSCAN5A DEGs, with 100 of the 363 ZSCAN5A DEGs 
being detected as similarly up- or down-regulated in the ZSCAN5B siRNA experiment 
(Table A.2). Since the ZSCAN5A knockdown experiments we analyzed did not reduce 
levels of ZSCAN5B and vice versa (Fig. 2.4), these data suggested some level of 
functional cooperation between the paralogous proteins in HEK-293 cells. Nevertheless 
the ZSCAN5B DEG set also emphasized some novel functions especially those related to 
tRNA and rRNA processing and modification (up-regulated) and microRNA processing 
(down-regulated) (Table 2.1). Interestingly, the tissues predicted to be affected by 
ZSCAN5 functions –including kidney, gut, cartilage, hematopoietic/lymphoid tissues, 
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and olfactory bulb - overlapped well with expression sites determined by qRT-PCR and 
ISH for the human and/or mouse genes (Table 2.1; Fig. 2.2, Fig. 2.3).    
 
ZSCAN5 proteins bind to tRNA genes and extra-TFIIIC sites in human 
and mouse 
 
ChIP with paralog-specific antibodies 
To identify reagents for detection of ZSCAN5 proteins, we identified commercial 
antibodies targeting ZSCAN5B and ZSCAN5D, and designed peptide epitopes from a 
sequence-divergent region of human ZSCAN5A and from the mouse Zscan5b protein to 
generate custom polyclonal antibodies (see Methods). These antibodies identified nuclear 
proteins of the correct size in BeWo and HEK-293 nuclear extracts (Fig. 2.4B). We 
further tested the specificity of these antibodies by examining protein extracted from 
HEK-293 cells after siRNA knockdown; densitometry revealed a reduction of 
ZSCAN5A, 5B, and 5D proteins by 84%, 67%, and 80%, respectively (Fig. 2.4B; Table 
A.3), confirming antibody specificity as well as providing additional support for the 
functional efficiency of siRNA knockdowns. 
We used the antibodies to human ZSCAN5A, ZSCAN5B, and ZSCAN5D for 
ChIP-seq in chromatin prepared from HEK-293 and BeWo cells, with chromatin from 
BeWo cells yielding by far the best results. ZSCAN5B peaks in BeWo chromatin were 
particularly clear, with very little background and strong enrichment in a limited number 
of genomic positions (a total of 672 peaks; 225 of which were detected with MACS 
software at a false discovery rate (fdr)=0; Table A.2). ZSCAN5A and ZSCAN5D ChIP 
experiments were plagued by a higher rate of background but also included larger 
numbers of highly and clearly enriched peaks. ZSCAN5A and ZSCAN5D ChIP 
experiments in chromatin from the HEK-293 cell line were not successful, but 
ZSCAN5B ChIP yielded a small numbers of clear peaks in this cell line. Because 
antibodies for all three proteins gave excellent results in BeWo chromatin, we focused on 
results from BeWo ChIP datasets for most types of peak analysis and used the ZSCAN5B 
HEK-293 ChIP experiments primarily for cell-to-cell comparisons and for functional 
studies including association of peaks with siRNA knockdown DEGs. 
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ZSCAN5B preferentially binds tDNA in human and mouse cells  
We noticed immediately that high-scoring ZSCAN5B peaks in both BeWo and 
HEK-293 chromatin coincided significantly with tRNA genes. Statistical analysis 
confirmed that the enrichment for tDNA sequences in the ZSCAN5B datasets, especially 
the fdr=0 subset of peaks, was very high (p=0; Table 2.2). Of all 672 ZSCAN5B BeWo 
peaks, 240 overlapped with tDNA sequences (Table A.2). In addition to these shared 
peaks, 15 HEK-293 peaks occupied tDNAs located directly adjacent to one bound by 
ZSCAN5B in BeWo chromatin in the same cluster, and 3 additional isolated tDNAs were 
detected uniquely in HEK-293 ChIP in the MACs analysis. The ZSCAN5B-bound 
tDNAs in both cell types correspond to a variety of different amino acids and codons 
without obvious enrichment of a particular type (Table A.2, Table A.4).  
To complement the human ZSCAN5B BeWo dataset, we also used the mouse 
Zscan5b antibody for ChIP-seq in chromatin isolated from dissected mouse fetal 
placenta. We identified 118 peaks, including many overlapping the homologs of the same 
tDNA sequences as those detected in ChIP experiments with human ZSCAN5B in 
syntenically homologous positions (Table A.5). These data confirmed that ZSCAN5B 
favors a specific subset of the same conserved tDNAs in different human cell types and 
in mouse placental tissue. 
Almost all of the highest-scoring ZSCAN5B and mouse Zscan5b peaks 
overlapped tDNAs, but ChIP-seq also detected enrichment in other types of Pol III 
transcripts including Vault RNA, 7SLRNA, and U6 snRNA; 200 of the 225 BeWo peaks 
detected with MACs at fdr=0 overlapped with this larger collection of Pol III genes. 
Accordingly, ZSCAN5B peaks were enriched for many of the same classes of RNA 
genes found to be occupied by Pol III (measured by ChIP with an antibody to the 
RPC155 subunit) and TFIIIC as reported by Moqtaderi and colleagues (Moqtaderi et al., 
2010) (Table 2.2). The small number of peaks that did not overlap with RNA Pol III 
genes were also interesting. For example, several individual peaks with high ChIP 
enrichment were found to overlie MIR and Alu SINE repeats, which are evolutionarily 
derived from tRNA and 7SL RNA, respectively (Ullu and Tschudi, 1984). One particular 
example, identified in human ZSCAN5B ChIP in BeWo and HEK-293 chromatin as well 
as mouse Zscan5b ChIP in fetal placenta corresponds to a MIR repeat located 
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approximately 1 kb downstream of the promoter of POLR3E, encoding the RPC5 subunit 
of Pol III (Table A.2). This particular MIR element has been shown to function as an 
enhancer for the POLR3E gene (Canella et al., 2012) suggesting that ZSCAN5B might 
regulate the expression of the Pol III subunit gene in some cellular contexts. 
 
ZSCAN5A and ZSCAN5D binding sites are also enriched in Pol III transcripts  
ZSCAN5A and ZSCAN5D binding sites were also highly enriched in tDNA 
sequences (Table 2.2). In fact, the three proteins appear to co-occupy many tDNA sites or 
to occupy neighboring tDNAs within the same genomic clusters although with different 
relative efficiencies. One particularly interesting set of examples is illustrated in Figure 
5A; the clustered tDNAs in this region are differentially marked by the human ZSCAN5 
proteins. These tDNAs, which surround the ALOXE3, HES7 and PER1 genes, have been 
shown to serve as anchors of local chromatin loops and to function as insulators in human 
cells (Raab et al., 2012). tDNAs throughout the genome also displayed ZSCAN5 protein-
specific peaks and for ZSCAN5B, cell type-specific enrichment patterns across the 
genome (Table A.2). These data suggest that the ZSCAN5A, B, and D proteins all bind to 
tDNA sequences but have different locus preferences within the same cell type; 
ZSCAN5B also clearly binds to specific tDNA loci more or less efficiently depending on 
the cellular context. 
  
Motif analysis reveals binding preferences for ZSCAN5 proteins 
 
ZSCAN5A and ZSCAN5B proteins bind G/C rich motifs  
We used the MEME suite (Bailey et al., 2009; Machanick and Bailey, 2011) to 
search for enriched sequence motifs enriched at the summits of the highest-scoring 
ZSCAN5A, ZSCAN5B and ZSCAN5D peak regions (see Methods). The analysis of 
ZSCAN5B peak summit regions revealed clear enrichment for a sequence including the 
TFIIIC-binding B box as the top-scoring, centrally located motif; Zscan5b peaks in 
mouse fetal placenta chromatin also yielded a very similar extended, central B Box motif 
(Fig. 2.5B). The A box motif typical to Pol III type 2 promoters was also identified as 
highly enriched in ZSCAN5B ChIP experiments although the motif was not central to the 
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peaks (not shown). It was not surprising to identify these motifs prominently in the 
ZSCAN5B peak datasets, since the A and B box elements in tDNAs are very distinct and 
well conserved between sites. However, the detected motifs also included less distinct 
G/C-rich DNA sequences extending beyond the B box sites (Fig. 2.5B). These extended 
motifs suggested that the true ZSCAN5B binding sites might be located in G/C-rich DNA 
surrounding the A and B box motifs.    
To gain more detailed information about the binding motif, we examined 133 
highly enriched (MACS enrichment factor or ef >10) ZSCAN5B BeWo peaks that were 
not associated with tDNAs. MEME analysis identified a long (29 bp) G-rich motif 
located centrally within the peaks. Adjusting MEME parameters to search for shorter 
motifs (since with 5 zinc fingers, ZSCAN5B is expected to bind at most to a 15 nt target 
region) identified two slightly different G/C-rich portions, which we call 5B_M1 and 
5B_M2 (Fig. 2.5C). A similar G/C-rich motif identified as highly enriched at centers of 
ZSCAN5A peak summits, bears a striking resemblance to the known binding motif for 
transcription factor and chromatin organizer, CTCF (Fig. 2.5D). The B Box-containing 
motif was also detected as enriched in ZSCAN5A peak summits but this motif was not 
detected as centrally located (not shown). Thus both ZSCAN5A and ZSCAN5B ChIP 
experiments identified G/C-rich motifs as potential binding sites. 
To ask whether the ZSCAN5B protein binds to the G-rich motifs, we selected one 
ZSCAN5B peak region for the “supershift” version of electrophoretic mobility shift 
assays (EMSA). The tDNAs are repetitive and mostly occupied by the very large Pol III 
protein complex; both properties complicate EMSA experiments. Therefore, we focused 
particularly on a non-tDNA peak uniquely detected with high efficiency by ZSCAN5B, 
which is located within an intron of the STAP2 gene (chr19:4328490-4328689). The peak 
summit region contains side-by-side high-scoring matches to 5B_M1 and 5B_M2 motifs. 
Biotin-labeled oligonucleotides were designed to span segments of the two peak regions 
including the motifs for EMSA testing (Fig. 2.6A).   
Both double-stranded oligonucleotides from the STAP2 intronic region were 
shifted after addition of the protein extract, although the 5B_M2 oligonucleotide and a 
longer oligonucleotide containing both 5B_M1 and 5B_M2 were shifted much more 
intensely. Addition of the ZSCAN5B antibody caused the smallest of three “shift” 
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complexes for 5B_M1 and the longer oligonucleotide with both motifs (arrowheads in 
Fig. 2.6B) to be supershifted efficiently. These data indicated that the preferred binding 
sequence for ZSCAN5B corresponds to the G/C-rich sequence commonly identified in 
the non-tRNA binding peaks. 
 
ZSCAN5D binding is enriched at MIR SINEs and LINE2-associated ETC motifs   
ZSCAN5D peaks did overlap with ZSCAN5A and ZSCAN5B at tDNAs, but the 
highest-scoring peaks for the ZSCAN5D antibody were distinctly bound. For example, 
more than half (56%) of the ZSCAN5D fdr=0 peaks mapped within 5 kb of a 
transcription start site (TSS); a similar count yielded only approximately 20% of 
comparable ZSCAN5A and ZSCAN5B peaks. Enriched repetitive element classes also 
distinguished ZSCAN5D peaks from those associated with ZSCAN5A or ZSCAN5B; 
instead ZSCAN5D more closely resembled TFIIIC ChIP binding peaks and ETC site 
enrichments (Table 2.2). Furthermore, analysis of ZSCAN5D binding peaks revealed a 
distinct set of enriched motifs. The first and most highly enriched motif identified in this 
peak dataset (5D_M1) corresponded to a novel sequence with a short GA-rich segment 
(Fig. 2.5E). The second significantly enriched motif found at the center of predicted 
ZSCAN5D summits, or 5D_M2 is notable because it is virtually identical to a novel 
ETC-associated motif identified previously in human cells (Moqtaderi et al., 2010) (Fig. 
2.5E). The two ZSCAN5D peak-enriched motifs were mostly distributed in distinct peak 
summits, although several ChIP summits contained both predicted motifs in close 
proximity.    
Closer inspection revealed that 5D_M1 mapped frequently within annotated MIR 
SINE repeats, while 5D_ M2 was contained within LINE2 (L2) elements; both of these 
repeat types were highly enriched in the ZSCAN5D ChIP peak dataset as well as ETC 
sites (Table 2.2). It is interesting to note that this L2-associated ETC motif is G/C rich 
and does bear some similarity to the G/C-rich motifs detected with ZSCAN5B and 
ZSCAN5A (Fig 2.5 C-E). These data suggest that despite fingerprint divergence, the 
primate-specific ZSCAN5 proteins likely recognize G/C-rich sites that are similar to the 
sites preferentially bound by parental ZSCAN5B. 
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ZSCAN5 protein binding influences expression of Pol III and nearby Pol II genes 
To ask whether ZSCAN5 protein binding might affect transcription of bound Pol 
III or nearby Pol II genes, we examined ZSCAN5 ChIP peaks that either mapped within 
or flanked DEGs detected after siRNA knockdown. Since knockdown data could only be 
reliably supplied by experiments in HEK-293 cells and ChIP was only successful in 
HEK-293 chromatin with the ZSCAN5B antibody, we focused primarily on peaks and 
nearby genes associated with ZSCAN5B in that cell line.  
ChIP data revealed that Pol III gene RMRP was bound internally by ZSCAN5B in 
both HEK-293 and BeWo cells and also at lower efficiency by ZSCAN5A in BeWo 
chromatin (Table A.2). This gene, encoding the RNA component of mitochondrial RNase 
P, represents one of the very few unique-sequence Pol III genes, a fact that permitted 
accurate measurement of RMRP transcript levels in RNA-seq experiments. RMRP was 
significantly up-regulated in both ZSCAN5B and ZSCAN5A siRNA experiments 
suggesting that ZSCAN5 protein binding suppresses expression of the gene (Fig. 2.7). 
Most other Pol III genes are highly repetitive and the RNA products fold into very stable 
secondary structures, so that expression is therefore difficult to measure accurately. 
However, primer sets that can detect a small number of tRNAs uniquely have been 
reported (Canella et al., 2012). Of the genes expressing these tRNAs, one was occupied 
by ZSCAN5A and ZSCAN5B in BeWo cells and ZSCAN5B in HEK-293; a second gene, 
encoding to a tRNA-Arg and located on chr9, was occupied by ZSCAN5A and 
ZSCAN5B in BeWo cells but not detected as bound by ZSCAN5B in HEK-293 cells 
(Table A.2). The other tRNA genes for which unique primer sets have been reported were 
not occupied by ZSCAN5A or ZSCAN5B proteins in ChIP experiments in either cell 
type. We selected two tRNA primer sets of each type (bound and unbound) to test 
expression after ZSCAN5 gene knockdown with qRT-PCR in HEK-293 cells, along with 
primers for RMRP. RMRP and the tRNA expressed from the tRNA bound in both cell 
types were up-regulated after siRNA knockdown; the tRNA expressed from the chr9 
gene not occupied by ZSCAN5B in HEK-293 cells was up-regulated only after 
knockdown of ZSCAN5A. In contrast, the expression of unbound tDNAs remain 
unchanged in expression (Fig 2.7). Although further studies will be required to test the 
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broader generality of this trend, these data support the hypothesis that ZSCAN5 proteins 
negatively regulate transcription of Pol III genes to which they are bound. 
Next we examined expression status of Pol II genes with transcription start sites 
(TSS) located very near (within 2 kb of) ZSCAN5B HEK-293 peaks. We identified 13 
ZSCAN5B DEGs of this type, including seven genes –HES7, TRIM7, NDUFS7, TIA1, 
C16orf13, and C17orf59, and Slc27a4 - located adjacent to tDNA peaks. Of these seven 
genes, TIA1 was down-regulated after ZSCAN5B knockdown while all others were up-
regulated. In the larger set of 13 adjacent genes including those adjacent to unique 
sequence peaks, all but TIA1 and PPP1R12A were up-regulated in the knockdown 
experiment suggesting that ZSCAN5B binding represses most adjacent genes.  
However, looking at all DEGs with promoters located further from ZSCAN5B 
HEK-293 peaks (within 20 kb, including both tDNA and non-tDNA peaks) this picture 
was more mixed, with 25 genes up-regulated and 13 genes down-regulated after 
ZSCAN5B siRNA knockdown (Table A.2). These data suggest a general trend toward 
repression, but also indicate that the effects of ZSCAN5 protein binding on nearby genes 
may not be as simple as a direct transcriptional repression or activation and may involve 
more complicated mechanisms. 
 
DISCUSSION 
 
Experiments reported here show that the ZSCAN5 family genes are actively 
expressed in rapidly dividing cell populations and that in those cells, the ZSCAN5 
proteins bind preferentially to Pol III transcription units, especially tDNAs, and related 
repetitive elements. The conserved progenitor of the primate family, ZSCAN5B, binds 
with high specificity to a particular subset of tDNA sequences in two human cell lines 
and strikingly, to the same subset of homologous tDNAs in chromatin of mouse fetal 
placenta. Although it is expressed at higher levels in human cells and displays a wider 
range of binding sequences, primate-specific ZSCAN5A also binds preferentially to 
tDNA, co-occupying many tDNA sites with ZSCAN5B. A functional cooperation 
between ZSCAN5A and ZSCAN5B proteins was further suggested by the high degree of 
similarity, in terms of gene identities as well as their up- or down-regulation, between the 
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DEGs that were detected after ZSCAN5A and ZSCAN5B siRNA knockdown. Since the 
human genes encode nearly identical SCAN elements, we surmise that it is likely that 
ZSCAN5 proteins interact as heterodimers through those domains.   
We identified a number of DEGs, including a mixture of up- and down-regulated 
genes, that flanked or contained ChIP peaks for ZSCAN5A, ZSCAN5B, or both; of the 
Pol II-expressed DEGs located within 2 kb of a ZSCAN5B HEK-293 ChIP peak, all but 
two were significantly up-regulated after ZSCAN5B siRNA knockdown suggesting that 
ZSCAN5B binding acts to repress transcription of those genes. The mechanism through 
which ZSCAN5 protein binding could regulate those genes will require further, in-depth 
study. However, based on our data and available data from other groups, we hypothesize 
that the effects on Pol II gene transcription may be a secondary effect of regulating the 
Pol III genes.    
Many previous studies have pointed clearly to a relationship between Pol III 
transcriptional activity and the expression of nearby Pol II genes. For example, in 
budding yeast, actively expressed tDNAs have long been known to exert repressive 
effects on nearby Pol II promoters, a phenomenon referred to as “tRNA gene-mediated 
silencing” (Hull et al., 1994; Kinsey and Sandmeyer, 1991). However available data from 
other species suggest a more complex relationship. In particular, tDNAs, MIR repeats, 
and other Pol III-transcribed sequences can serve enhancer-blocking or barrier-insulating 
functions, with varying effects on flanking Pol II genes. For example, higher levels of Pol 
III recruitment to promoter-linked MIR elements resulted in significant enhancement of 
CDKN1A and GDF15 gene expression in human cells. In the case of GDF15, Pol III 
activity was shown to be required for formation of a chromatin loop that activates 
transcription of the Pol II gene (Lee et al., 2015). However, loop structures can also lead 
to gene repression through enhancer blocking and other mechanisms (Comet et al., 2011; 
Jiang and Peterlin, 2008; Kirkland et al., 2013; Li et al., 2008; Van Bortle and Corces, 
2012). Our data suggest that ZSCAN5B binding represses Pol III transcription, and we 
speculate that through this mechanism, ZSCAN5B modulates the formation of chromatin 
loops at bound tDNAs and interacting sites. If this hypothesis is correct, the positive or 
negative effects of ZSCAN5 binding on nearby Pol II genes could be subtle, depending 
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on distance from the peak and on the particular types of interactions between enclosed 
genes and the anchors of the modulated chromatin loops. 
Whether directly or indirectly, ZSCAN5A and ZSCAN5B knockdown robustly 
affected the expression of large sets of functionally coherent genes, which together 
provide clues to the ZSCAN5 proteins’ ultimate biological functions. ZSCAN5A has 
been previously reported as one of 850 genes differentially regulated during the cell 
cycle, with peak expression during the G2/M transition (Whitfield et al., 2002), and 
consistent with this finding, knockdown of ZSCAN5A predicted that the protein 
negatively regulates processes involved in chromosome segregation and metaphase-
anaphase transition. Positively regulated genes, by contrast, were enriched in functions 
related to cellular differentiation, with genes active in development of lung, gut, blood 
vessels, neurons, immune cells, and several other tissues in which the ancestral mouse 
gene is actively expressed during embryogenesis. Together these data suggest that in 
vivo, ZSCAN5A may regulate cell cycle exit and differentiation in a variety of precursor 
cell types. 
ZSCAN5B knockdown revealed additional cellular functions, related to tRNA 
maturation and modification events. These predicted functions fit well with the 
hypothesis that ZSCAN5B binding also negatively regulates the synthesis of tRNA 
genes. Here we should note that in addition to the essential functions tRNAs serve in 
protein synthesis, tRNA processing generates fragments that functions as microRNAs 
and serve independent signaling functions; the regulation of tRNA processing, per se, 
may thus exert profound influences on gene expression and cellular state (Kirchner and 
Ignatova, 2015). 
Indeed, many of the biological functions suggested for ZSCAN5 proteins may be 
encapsulated by a brief summary of known functions for RMRP, a Pol III-transcribed 
gene and directly repressed target of ZSCAN5A and ZSCAN5B. RMRP plays a critical 
role in processing of ribosomal RNAs, mitochondrial tRNAs, and microRNA precursors 
(Martin and Li, 2007) and also processes cellular mRNAs, most notably degrading Cyclin 
B2 mRNA to permit cell cycle progression at the end of mitosis (Gill et al., 2004). RMRP 
mutations are associated with cartilage hair hypoplasia-Anauxetic dysplasia (CHH-AD) 
spectrum disorders, associated with a range of symptoms including short-limbed 
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dwarfism, skeletal dysplasia, hair abnormalities, immunodeficiency and bone marrow 
failure, gastrointestinal disorders, cognitive defects, and cancer susceptibility (Martin and 
Li, 2007; Thiel et al., 2007). Rather than being caused simply by loss of RNAse P 
function per se, many CHH-AD symptoms are thought to reflect malfunction of RMRP-
derived microRNAs that serve to target and down-regulate essential developmental genes 
(Rogler et al., 2014). Disruptions in expression of this target locus could thus set off a 
cascade of events with significant downstream consequences. 
 Because we could not knock down ZSCAN5D with siRNA specifically, the 
biological functions of this primate-specific paralog remain something of a mystery. 
However, our data show that ZSCAN5D protein displays highest preference for tDNA-
derived MIR SINE sites and a subset of LINE2 elements that harbor a previously 
identified ETC motif (Moqtaderi et al., 2010). L2 elements have carried the transposition-
deficient MIR SINEs as “hitchhikers”, and remnants of the two repeats can often be 
found closely juxtaposed (Gilbert and Labuda, 2000). The high enrichment of both 
ZSCAN5D and the human ETCs in MIR SINE and L2 repetitive elements (Table 2.2), 
suggests that a subset of ETC sites were distributed as MIR-associated L2 repeats during 
early mammalian evolution, and that these ETCs have evolved as preferred binding sites 
for ZSCAN5D. Further studies will be required to address these hypotheses definitively. 
In closing, we note that this TF gene family was elaborated, first in eutherians and 
further in early primate lineages, to regulate one of the most ancient mechanisms known 
to control three-dimensional chromatin architecture in eukaryotic cells. We surmise that 
ZSCAN5B evolved in early eutherian history to add a novel layer of regulation on a 
subset of Pol III-transcribed genes, modulating their transcription and their chromatin-
organizing functions. The new primate paralogs diverged in fingerprint structure but 
retained a preference for a similar G-rich binding motif to co-bind with ZSCAN5B at 
many tDNA sites, likely dimerizing through their nearly identical SCAN domains. 
Through modulation of Pol III transcription and position effects on neighboring genes, 
our data suggest that human ZSCAN5A and ZSCAN5B collaborate in control of 
noncoding RNA processing, cell cycle progression and differentiation in many tissues. 
Although functional understanding of ZSCAN5D is complicated and still incomplete, the 
observation that this primate-specific protein binds to MIR-repeat derived ETCs offers a 
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potentially valuable clue to the evolution of mammalian chromatin structure and deserves 
further investigation. 
 
MATERIALS AND METHODS 
 
ETHICS STATEMENT 
This investigation has been conducted in accordance with the ethical standards 
and according to the Declaration of Helsinki and according to national and international 
guidelines. All animal work was reviewed and approved by the University of Illinois 
IACUC committee under protocol number 15425.   
 
RNA PREPARATION AND QUANTITATIVE RT-PCR 
Total RNA was isolated from cell lines and tissues using TRIzol (Invitrogen) 
followed by 30 minutes of RNase-free DNaseI treatment (NEB) at 37oC and RNA Clean 
& ConcentratorTM-5 (Zymo Research). 2 µg of total RNA was used to generate cDNA 
using Superscript III Reverse Transcriptase (Invitrogen) with random hexamers 
(Invitrogen) according to manufacturer’s instructions.  
Resulting cDNAs were analyzed of transcript-specific expression through 
quantitative reverse-transcript PCR (qRT-PCR) using Power SYBR Green PCR master 
mix (Applied Biosystems) with custom-designed primer sets (Table A.6) purchased from 
Integrated DNA Technology. Relative expression was determined by normalizing the 
expression of all genes of interest to either human or mouse Tyrosine 3-
monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide 
(YWHAZ) expression (∆Ct) as described (Eisenberg and Levanon, 2003).   
 
IN SITU HYBRIDIZATION  
Mouse embryos were collected, paraffin embedded, sectioned and hybridized 
with an antisense RNA probe, essentially as previously described (Kim et al., 2001). We 
generated In Situ hybridization (ISH) probes correspond to nucleotides of the mouse 
Zscan5b cDNA sequence (NM_133204), and to human ZSCAN5B (NM_001080456) 
(see Table A.6 for probe sequences). Probes were cloned into the pGEM-T vector 
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(Promega) and sequence-validated before being used for ISH. The reverse primer 
included a T7 promoter sequence to permit antisense RNA generation using the Roche 
DIG RNA Labeling kit (SP6/T7) (Roche Applied Science) according to manufacturer’s 
instructions. To prepare human tissue arrays, paraffin blocks containing formalin-fixed 
tissues from normal anonymous adult donors were purchased from NoblePath Inc. Tissue 
microarray (TMA) blocks were generated using a Tissue Arrayer (Beecher Instruments). 
The pre-cut paraffin tissue sections were checked by H&E staining for tissue index 
selection. Forty-one 1.5mm diameter cores were included in the arrays, with 2 cores 
included to represent different regions of some tissues (x2). High quality 4-micron 
sections were generated using a Leica ST 2155 microtome. Slides were baked at 41o C 
overnight and stored at -20oC until use. Slides were pretreated and hybridizations were 
performed as described previously (Kim et al., 2000). Sections were mounted using 
Vectashield Mounting Medium with DAPI. Fluorescent images were reviewed using an 
Olympus BX60 microscope and captured by an Olympus CC-12 digital camera. 
 
CELL CULTURE AND TRANSFECTIONS 
HEK-293 (ATCC, CRL-1573), Neuro-2a (ATCC, CCL-131), and BeWo (ATCC, 
CCL-98) cell lines were obtained from the American Type Culture Collection. HEK-293 
and Neuro-2a cells were maintained in Dulbecco's Modified Eagle's Medium (DMEM) 
containing 2 mM L-glutamine, 10% fetal bovine serum (FBS), 1X Pen Strep, and BeWo 
cells in DMEM/F12K containing 2 mM L-glutamine, 10% FBS, 1X NEAA, 1X Pen 
Strep, incubated at 37 °C in 5% CO2.  
For siRNA knockdown, approximately 4.5x105 HEK-293 cells were seeded to 6-
well plates 24 hours before transfection. Cells were treated with 10 nM of siRNA specific 
to each ZSCAN5A (si4: SI00779436, si5: SI04221826, Qiagen) or ZSCAN5B (si1: 
SI00503300, Qiagen), or ZSCAN5D (si2: SI02804774, Qiagen) with a scrambled 
negative control (Silencer negative control No.1 siRNA, Ambion) for 48 hours using 
Lipofectamine RNAi MAX transfection reagent (Invitrogen) according to manufacturer’s 
instructions. (See Table A.6) 
 
 
 49 
RNA-SEQ AND COMPUTATIONAL ANALYSIS 
48 hours after siRNA treatment, total RNA was prepared and tested for quality 
using an Agilent BioAnalyzer and Illumina libraries generated using the KAPA Stranded 
mRNA-Seq kit with mRNA Capture Beads (Kapa Biosystems, KK8420). Sequencing 
was performed on an Illumina Hi-Seq 2000 instrument at the University of Illinois Roy J. 
Carver Biotechnology sequencing facility, to yield 60-65 million reads per sample. The 
data have been submitted to the Gene Expression Omnibus database (accession numbers, 
in progress). 
RNA-seq data were analyzed using the Tophat-Cufflinks Suite of tools (Trapnell 
et al., 2012). For ZSCAN5A knockdown, expression results from si4 and si5 were 
analyzed as a group in comparison with the scrambled control. Genes identified as 
differentially expressed with p < 0.05 (after Benjamini-Hochberg correction for multiple 
testing) compared to the negative control-treated samples were considered for further 
analysis. For ZSCAN5B knockdown, which was effective only for a single siRNA design, 
we considered all genes with expression levels of at least 1 FPKM in at least one sample 
and considered genes with > 1.5 X fold change relative to scrambled control as DEGs. 
siRNA up-regulated and down-regulated genes were analyzed for function separately 
using the DAVID (Huang et al., 2007a) functional clustering algorithm with default 
settings.  
 
PROTEIN PREPARATION, WESTERN BLOTS, AND ANTIBODIES 
Nuclear Extracts were prepared with NucBusterTM Protein Extraction Kit 
(Novagen) and measured by Bradford-based assay (BioRad). The extracts were stored at 
-80oC and thawed on ice with the addition of protease inhibitor Cocktail (Roche) directly 
before use. 15 µg of nuclear extracts were run on 10% acrylamide gels and transferred to 
hydrophobic polyvinylidene difluoride (PVDF) membrane (GE-Amersham, 0.45 µm) 
using BioRad Semi-dry system, then visualized by exposure to MyECL Imager (Thermo 
Scientific).  
Rabbit polyclonal antibodies were generated by injection of synthetic peptides 
corresponding to the tether regions of ZSCAN5A (DLVRAKEGKDPPKIAS) and mouse 
Zscan5b proteins (CPEPANPQPEKQVDSL); peptide synthesis, antibody production, 
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and affinity purification of antibodies against the purified peptide epitope we carried out 
by Abgent Inc. ZSCAN5B (sc-249845, Santa Cruz Biotechnology) and ZSCAN5D 
(ARP47809_P050, Aviva Systems Biology) antibodies were obtained from commercial 
sources. Antibody preparations were tested for protein specificity and efficiency by 
Western blot staining along with anti-TATA binding protein control antibody (1TBP18, 
Abcam) 
 
CHROMATIN IMMUNOPRECIPITATION 
Chromatin immunoprecipitation was carried out as essentially as described (Kim 
et al., 2003) with modifications for ChIP-seq. Chromatin was prepared from HEK-293, 
BeWo, and Neuro-2a cell lines. About 1.0 x 106 Cells were fixed in PBS with 1% 
formaldehyde for 10 minutes. Fixing reaction was stopped with addition of Glycine to 
0.125M. Fixed cells were washed 3x with PBS+Protease inhibitor cocktail (PIC, Roche) 
to remove formaldehyde. Washed cells were lysed to nuclei with lysis solution – 50 mM 
Tris-HCl (pH 8.0), 2 mM EDTA, 0.1% v/v NP-40, 10% v/v glycerol, and PIC – for 30 
minutes on ice. Cell debris was washed away with PBS with PIC. Nuclei were pelleted 
and flash-frozen on dry ice. 
 To obtain chromatin samples from mouse fetal placenta, pregnancies were 
identified in C57BL/6J females by detection vaginal plugs (day of plug detection is 
E0.5), and placentas were dissected at E17.5. After removing maternal decidua, samples 
were homogenized in cold PBS containing PIC using a loose-fitting Dounce 
homogenizer. Debris was removed using cell strainer (Fisher Scientific), and single cell 
suspension was washed twice with cold PBS. Viable cells were counted using 
hemocytometer and crosslinked with 4% paraformaldehyde (Electron Microscopy 
Sciences) for 10 minutes at room temperature before nuclear isolation.  
Cross-linked chromatin was prepared and sonicated using Bioruptor UCD-200 in 
ice water bath to generate DNA fragments 200-300 bp in size. Twenty micrograms of 
each antibody preparation, or 20 µg IgG for mock pulldown controls, were incubated 
with chromatin prepared from nuclei of approximately 5 million cells.  
DNA was released and quantitated using Qubit 2.0 (Life Technologies) with 
dsDNA HS Assay kit (Life Technologies, Q32854), and 15 ng of DNA was used to 
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generate libraries for Illumina sequencing. ChIP-seq libraries were generated using 
KAPA LTP Library Preparation Kits (Kapa Biosystems, KK8232) to yield two 
independent ChIP replicates for each antibody. We also generated libraries from 
sonicated genomic input DNA from the same chromatin preparations as controls. 
Libraries were bar-coded with Bioo Scientific index adapters and sequenced to generate 
15-23 million reads per duplicate sample using the Illumina Hi-Seq 2000 instrument at 
the University of Illinois W.M. Keck Center for Comparative and Functional Genomics 
according to manufacturer’s instructions. Separate ChIP preparations were generated for 
qRT-PCR validation experiments; in this case, released DNA was amplified by 
GenomePlex® Complete Whole Genome Amplification (WGA) Kit (Sigma, WGA2).  
 
CHIP-SEQ DATA ANALYSIS 
Human ZSCAN5A, ZSCAN5B, and ZSCAN5D ChIP-enriched sequences as well 
as reads from the input genomic DNA were mapped to the HG19 human genome build, 
and Mouse Zscan5b ChIP reads and input mapped to the mouse Mm9 genome assembly, 
using Bowtie 2 software (Langmead et al., 2009) allowing 1 mismatch per read but 
otherwise using default settings. Bowtie files were used to identify peaks in human ChIP 
samples using MACS software (version 14.2) (Zhang et al., 2008), with default settings. 
All samples, including the Mouse Zscan5b and human ZSCAN5B ChIP samples isolated 
from HEK-293 cells, both of which had higher levels of background compared to other 
samples generated, were also analyzed using the more sensitive HOMER software 
package (http://homer.salk.edu/homer/ngs/index.html) using default conditions for the TF 
setting and false discovery rate cutoffs of 0.1 (mouse Zscan5b ChIP) or 0.01 (for ChIP in 
human HEK-293 and BeWo chromatin). After comparison of the individual files, 
sequence reads from the two separate ChIP libraries were pooled and a final peak set 
determined in comparison to genomic-input controls. Peaks were mapped relative to 
nearest transcription start sites using the GREAT program (McLean et al., 2010). Peak 
locations provided by Moqtaderi et al. (Moqtaderi et al., 2010) and Oler et al. (Oler et al., 
2010) were converted to Hg19 coordinates using the Liftover utility provided by the 
UCSC genome browser (https://genome.ucsc.edu/), and overlaps between these peaks 
and ZSCAN5 ChIP data were determined. DEGs and ChIP peaks, with overlaps to these 
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other datasets and repeat-sequence mapping are summarized in Table A.2 for human cell 
types and Table A.5 for mouse fetal placenta ChIP.   
 
REPETITIVE ELEMENT OVERLAP ANALYSIS 
To identify enrichment or under-representation of repetitive element types or 
families in the ChIP-peak datasets, we used a method modified from that described by 
Cuddapah and colleagues (Cuddapah et al., 2009). Human repeat data were retrieved on 
11/25/2013 as the RepeatMasker Table (www.repeatmasker.org) from USCS’s table 
browser (genome.ucsc.edu) (Karolchik et al., 2004) with the following parameters: 
assembly= ‘Feb. 2009 (GRCh37/hg19)’, group= ‘Variation and Repeats’, track= 
‘RepeatMasker’, table= ‘rmsk’, region= ‘genome’, output format= ‘BED – Browser 
extensible data’. The human chromosome sizes required for the analysis were retrieved 
on 2/20/2014 from the hg19.chromInfo table of the UCSC public database (Kuhn et al., 
2013). We examined overlap between genome coordinates of repeat element features and 
100 bp intervals surrounding the summits of peaks determined by MACS software from 
ZSCAN5A, ZSCAN5B, and ZSCAN5D ChIP experiments (986 peaks with FDR=0 or 
effective fold change ≥ 15 for ZSCAN5A_BeWo_ef15; 225 peaks with FDR=0 for 
ZSCAN5B_BeWo; 1885 peaks with FDR=0 for ZSCAN5D_BeWo, and all 102 peaks 
reported by MACS for ZSCAN5B_HEK-293) using the BEDTools intersect function 
(Quinlan and Hall, 2010). Overlaps were also determined for peak sets from Moqtaderi 
and colleagues (Moqtaderi et al., 2010) after applying the UCSC liftover ultility to 
identify coordinates in the human hg19 genome build (ETC with 1865 200 bp peaks; 
RPC155 with 1518 200 bp peaks; and TFIIIC with 5472 200 bp peaks). 
For each peak set 500 random sets of the same number and peak size were 
generated by the BEDTools random function, and overlaps between these random peak 
sets and repeats were counted for each of the 500 random sets. For each repeat element 
and family the average overlap count of the random sets and the standard deviation was 
determined. Then for each repeat element and family a Z-score was calculated using the 
overlap count of the peak set, and the average overlap count and standard deviation of the 
random sets. 
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If the overlap count of the peak set was less than or equal to the average of the 
random sets z was calculated as: 𝑧𝑧 =(𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜 𝑐𝑐𝑜𝑜𝑐𝑐𝑐𝑐𝑐𝑐 𝑜𝑜𝑜𝑜 𝑜𝑜𝑜𝑜𝑜𝑜𝑝𝑝 𝑠𝑠𝑜𝑜𝑐𝑐) − (𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑎𝑎𝑜𝑜 𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜 𝑐𝑐𝑜𝑜𝑐𝑐𝑐𝑐𝑐𝑐 𝑜𝑜𝑜𝑜 𝑜𝑜𝑜𝑜𝑐𝑐𝑟𝑟𝑜𝑜𝑟𝑟 𝑠𝑠𝑜𝑜𝑐𝑐𝑠𝑠)
𝑠𝑠𝑐𝑐𝑜𝑜𝑐𝑐𝑟𝑟𝑜𝑜𝑜𝑜𝑟𝑟 𝑟𝑟𝑜𝑜𝑜𝑜𝑑𝑑𝑜𝑜𝑐𝑐𝑑𝑑𝑜𝑜𝑐𝑐 𝑜𝑜𝑜𝑜 𝑐𝑐ℎ𝑜𝑜 𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜 𝑐𝑐𝑜𝑜𝑐𝑐𝑐𝑐𝑐𝑐 𝑜𝑜𝑜𝑜 𝑜𝑜𝑜𝑜𝑐𝑐𝑟𝑟𝑜𝑜𝑟𝑟 𝑠𝑠𝑜𝑜𝑐𝑐𝑠𝑠 . If the overlap count of the 
peak set was greater: z = (𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑎𝑎𝑜𝑜 𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜 𝑐𝑐𝑜𝑜𝑐𝑐𝑐𝑐𝑐𝑐 𝑜𝑜𝑜𝑜 𝑜𝑜𝑜𝑜𝑐𝑐𝑟𝑟𝑜𝑜𝑟𝑟 𝑠𝑠𝑜𝑜𝑐𝑐𝑠𝑠) − (𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜 𝑐𝑐𝑜𝑜𝑐𝑐𝑐𝑐𝑐𝑐 𝑜𝑜𝑜𝑜 𝑜𝑜𝑜𝑜𝑜𝑜𝑝𝑝 𝑠𝑠𝑜𝑜𝑐𝑐)
𝑠𝑠𝑐𝑐𝑜𝑜𝑐𝑐𝑟𝑟𝑜𝑜𝑜𝑜𝑟𝑟 𝑟𝑟𝑜𝑜𝑜𝑜𝑑𝑑𝑜𝑜𝑐𝑐𝑑𝑑𝑜𝑜𝑐𝑐 𝑜𝑜𝑜𝑜 𝑐𝑐ℎ𝑜𝑜 𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜 𝑐𝑐𝑜𝑜𝑐𝑐𝑐𝑐𝑐𝑐 𝑜𝑜𝑜𝑜 𝑜𝑜𝑜𝑜𝑐𝑐𝑟𝑟𝑜𝑜𝑟𝑟 𝑠𝑠𝑜𝑜𝑐𝑐𝑠𝑠 . 
The R function pnorm(z) was used to calculate a p-value to indicate if the overlap count 
was significantly under-represented or enriched in a ChIP-peak set when compared to the 
overlap counts of the random sets. Repeat families or specific elements that were 
significantly enriched in at least one of the ChIP peak sets are reported in Table 2.2 and 
Table A.4, respectively, along with p-values determined for enrichments or under-
representation of that family or element type in each peak set. 
 
MOTIF ANALYSIS  
To identify enriched motifs, we used sequence from a 200 bp region surrounding 
the predicted summits of selected peaks for analysis with MEME-ChIP with default 
parameters (Machanick and Bailey, 2011). Motifs displayed in Fig. 5 were identified 
from peaks with the following cutoffs: (panel B) All HOMER-derived peaks for mouse 
Zscan5b ChIP in fetal placenta chromatin; (2) All HOMER peaks with enrichment (ef) > 
20 in human ZSCAN5B ChIP with HEK-293 chromatin; and All MACS ef > 20, fdr=0 
peaks from ZSCAN5B ChIP in BeWo chromatin; (panel C) all peaks except those 
overlying tDNAs, identified with MACS in BeWo chromatin with ef >10; (panel D and 
E) ZSCAN5A and ZSCAN5D peaks identified with MACS at ef >20. Only the top peaks 
identified in each analysis are shown, as described in the text.  
 
SUPERSHIFT ELECTROPHORETIC MOBILITY SHIFT ASSAY  
Nuclear extracts from subconfluent HEK-293 cells were prepared with 
NucBusterTM Protein Extraction Kit (Novagen) and measured by Bradford-based assay 
(BioRad). Probes were synthesized as double stranded oligonucleotides by annealing 2 
µg of biotin 5’-end labeled single stranded oligonucleotides and unlabeled 
complementary single stranded oligonucleotides (Integrated DNA Technology) in 
annealing buffer (10 mM Tris-HCl, pH7.5, 50 mM NaCl, 1 mM EDTA). Mixed 
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oligonucleotides were heated in 95oC hot block for 10 minutes and slowly cooled down 
to room temperature. The sequences of the probes used were as follows: STAP2_M2 
forward (5’biotin- CGGGTCGGACTCCGCCCCTGCTTCTGA-3’) and reverse (5’-
TCAGAAGCAGGGGCGGAGTCCGACCCG-3’); STAP2_M1 forward (5’biotin-
CTGACCACGCCCCCGCGCCCACCCTCTT-3’) and reverse (5’-
AAGAGGGTGGGCGCGGGGGCGTGGTCAG-3’); STAP2_M2+M1 forward (5’biotin-
CGGGTCGGACTCCGCCCCTGCTTCTGACCACGCCCCCGCGCCCACCCTCTT-3’) 
and reverse (5’-
AAGAGGGTGGGCGCGGGGGCGTGGTCAGAAGCAGGGGCGGAGTCCGACCCG
-3’). EMSA binding reactions were performed at room temperature for 30 minutes and 
consisted of 3 µg of nuclear extract in 1X binding buffer, 2.5% glycerol, 5 mM MgCl2, 
50 ng/µl poly(dI-dC), 0.05% NP-40, and 20 ng of biotinylated DNA probes. For 
supershift reactions, 5 µg of antibody targeting ZSCAN5B was carefully added and 
mixed, and incubated for additional 30 minutes at room temperature. The mixture was 
run on 6% non-denaturing polyacrylamide gels in 1X Tris borate-EDTA buffer. Protein-
DNA complexes were then transferred to PVDF membrane using the BioRad Semi-dry 
system and cross-linked using the Spectrolinker XL-1000 UC cross-linker (Spectronics 
Corp.). Detection of biotin-labeled DNA was performed using the LightShift 
chemiluminescent EMSA kit (Thermo Scientific) and visualized by exposure to MyECL 
Imager, a charge-coupled device camera (Thermo Scientific). 
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FIGURES 
Figure 2.1. 
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Figure 2.1. (cont.) DNA-binding “fingerprint” patterns for primate-specific 
ZSCAN5 proteins 
The fingerprints of the novel duplicates have diverged relative to the ancestral gene copy, 
but once generated, these patterns have been conserved in primate species. Amino acid 
residues corresponding to DNA-binding positions (1-, 2, 3, and 6 relative to the alpha 
helix) in each of the five zinc fingers in ZSCAN5 proteins predicted from mouse, human, 
and marmoset genomes are shown aligned in the 5’->3’ order of the zinc fingers in each 
gene. Mouse and other mammals contain a single gene, Zscan5b, which was duplicated in 
early primate history to generate three new gene copies: ZSCAN5A, ZSCAN5C, and 
ZSCAN5D (Mm_Zscan5b: ENSMUSG00000058028, Cj_ZSCAN5B: 
ENSCJAG00000020279, Hs_ZSCAN5B: ENSG00000197213, Cj_ZSCAN5A: 
ENSCJAG00000037918, Hs_ZSCAN5A: ENSG00000131848, Cj_ZSCAN5C: 
ENSCJAG00000020275, Hs_ZSCAN5C: ENSG00000204532, Cj_ZSCAN5D: 
ENSCJAG00000014787, Hs_ZSCAN5D: ENSG00000267908). 
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Figure 2.2. 
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Figure 2.2. (cont.) ZSCAN5 family exhibits overlapping but distinct patterns of 
tissue-specific expression in human tissues 
Relative transcript levels were measured in cDNA prepared from total RNA from human 
tissues by qRT-PCR for (A) human ZSCAN5A, (B) ZSCAN5B, (C) ZSCAN5D, and from 
mouse tissues for (D) mouse Zscan5b. Relative expression was normalized for other 
tissues compared to expression level in testis, which was set as 10. Error bars correspond 
to the variance between experimental triplicates. 
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Figure 2.3. 
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Figure 2.3. (cont.) In situ hybridization in sectioned embryos and adult human 
tissues shows that ZSCAN5B expression is highest in rapidly dividing cell 
populations 
Sagittal sections of paraffin embedded mouse embryos at E14.5, E16.5, and E18.5 were 
hybridized with a Zscan5b antisense RNA probe detected with TSA-Rhodamine (Red), 
against a DAPI counterstain (blue). (A) Whole sectioned E14.5 embryo shows tissues 
overall expression, with higher magnification panels showing expression in (B) forebrain 
(fb), as well as (C) heart (he) and alveoli of the lung (lu). At E16.5, high levels of 
expression were detected in olfactory bulb (D), and thymus (E). By E18.5, high levels of 
expression had faded from heart and lung but were predominant in (F) muscle (mu) and 
skin (sk), and (G) cartilage (ca). In human adult tissues, the ZSCAN5B gene was detected 
at particularly high levels in (H) skin epithelium (sk), (I) small intestine (si), (J) testicular 
spermatocytes (te) and (K) lung (lu), and bone marrow granulocytes (bm). Scale bar 
corresponds to 100 µm. 
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Figure 2.4. 
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Figure 2.4. (cont.) siRNA knockdown of ZSCAN5 and antibody specificity  
HEK-293 cells were transfected with either 10 nM of scrambled siRNA control (Ctrl) or 
siRNAs targeting ZSCAN5A (si4, si5), ZSCAN5B (si1), or ZSCAN5D (si2) for 48 
hours, and RNA and nuclear extracts were collected. (A) qRT-PCR of each sample 
showed 71.6% (si4) and 72.6% (si5) knockdown of ZSCAN5A transcripts, 76.9% (si1) 
knockdown of ZSCAN5B transcripts, and 67.6% (si2) knockdown of ZSCAN5D 
transcripts compared to the scrambled control. (B) To confirm knockdown of each 
protein and verify antibody specificities, Western blots were performed on cell extracts 
from cells after treatment with gene-specific siRNA or scrambled control, using 
antibodies targeting ZSCAN5A, ZSCAN5B, and ZSCAN5D. TATA-binding protein 
(TBP) was used as an internal control. Correct band sizes were detected at 56 kDa 
(ZSCAN5A, ZSCAN5B, ZSCAN5D), and 38 kDa (TBP). Densitometric analyses of 
band intensity using Image J (Schneider et al., 2012) showed 84.1% (ZSCAN5A), 67.0% 
(ZSCAN5B), and 80.0% (ZSCAN5D) decrease of each protein after siRNA knockdown 
(Table A.3). 
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Figure 2.5. 
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Figure 2.5. (cont.) ZSCAN5 binding displays a protein- and cell type-specific 
preference for tDNAs and other Pol III-related loci enriched in G/C rich motifs  
(A) Distribution of ChIP-seq read peaks in the HES7 region are displayed in a snapshot 
from the UCSC browser. ChIP read pileups are shown in red, with the distribution of 
background reads from genomic input are displayed in brown. Peaks from ZSCAN5B in 
chromatin from two cell lines, HEK-293 and BeWo, shown together with peak profiles 
from ZSCAN5A and ZSCAN5D ChIP in BeWo chromatin, reveal strong enrichment 
over tRNA genes that are clustered in the region; arrows in peak tracks highlight peaks 
that are differentially enriched by ZSCAN5B ChIP in the two cell types, or in ChIP with 
ZSCAN5B compared to ZSCAN5A or ZSCAN5D. (B) Motifs detected as most highly 
enriched and central in ChIP peaks for mouse Zscan5b and human ZSCAN5B in HEK or 
BeWo cells include the TFIIIC-binding B-box, which is present and highly conserved in 
all expressed tDNAs, and G/C-rich surrounding DNA. (C) A motif search conducted after 
removing tDNA sequences from the ZSCAN5B BeWo peak set revealed G/C-rich 
sequences, including an extended motif as well as two shorter motifs (5B_M1, 5B_M2) 
as predicted ZSCAN5B binding motifs. (D) A G/C rich central motif was also detected in 
analysis of ZSCAN5A ChIP peaks; a portion of this motif bears striking resemblance to 
the known motif for transcription factor and insulator protein, CTCF. (E) A distinct set of 
motifs were detected in high-scoring ZSCAN5D peaks, including a G/C rich motif, 
5D_M2, bearing strong similarity to a novel ETC motif detected by Moqtaderi and 
colleagues (Moqtaderi et al., 2010).  
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Figure 2.6. 
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Figure 2.6. (cont.) ZSCAN5B proteins bind G/C rich motifs 
To confirm that the ZSCAN5B protein binds to the G-rich motifs, we tested the summit 
region of a non-tDNA peak uniquely detected with high efficiency by ZSCAN5B, located 
within an intron of the STAP2 gene (human assembly GRCh37, chr19:4,328,490-
4,328,689), which includes both the predicted 5B_M1 and 5B_M2. (A) Biotin-labeled 
oligonucleotides were designed to cover fragments of the two peak regions including the 
5B_M2 (boxed, left) and 5B_M1 (boxed, right) motifs. Labeled probes containing 
5B_M2 were named “STAP2_M2” (27 bp), 5B_M1 as “STAP2_M1” (28 bp), or 5B_M2 
and 5B_M1, and an oligonucleotide probe containing both sequences was named 
“STAP2_M2+M1” (51 bp). (B) Nuclear extracts (NE) to which a biotinylated probe 
(Labeled probe) had been added for “shift”, with or without the anti-ZSCAN5B antibody 
(αZSCAN5B) for “supershift” were resolved on 6% non-denaturing polyacrylamide gels. 
Addition of αZSCAN5B caused the effective supershift of the lowest band of three 
“shift” complexes for STAP2_M1 and STAP2_M2+M1 (arrowheads). Asterisks indicate 
unbound biotinylated DNA probes. 
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Figure 2.7. 
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Figure 2.7. (cont.) Differential expression of ZSCAN5-bound RMRP and tRNAs 
qRT-PCR was done to measure the differential expression of gene loci that are bound and 
unbound by ZSCAN5A and ZSCAN5B after ablation of each gene by siRNA treatments 
in HEK-293 cells. Error bars correspond to the standard deviations between experimental 
triplicates.   
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TABLES 
 
Table 2.1. Gene Ontology (GO) clusters identified as significantly enriched in gene 
sets up- or down-regulated after ZSCAN5 gene siRNA knockdown 
1 Calculated as the geometric mean (in – log scale) of P values for clustered terms, as described in 
Huang et al., 2009. An enrichment of 1.3 corresponds roughly to a combined P value of 0.05.  
The top-scoring term for each cluster is reported. 2, 3 Clusters associated with Up- or Down-regulated 
genes, respectively. 
 
 DAVID Functional cluster 
ZSCAN5A 
(DAVID 
enrichment 
factor) 1 
ZSCAN5B 
(DAVID 
enrichment 
factor) 
Up2 Down3 Up Down 
Ribonucleotide complex/ribosome biogenesis 9.6    
M-phase/cell cycle 5.0    
Chromosome segregation/spindle 3.1    
Ubiqutin ligase complex/unfolded protein binding 2.4    
Regulation of metaphase/anaphase transition 2.2    
Condensed chromosome/kinetochore 1.9  1.9  
M-phase of meiotic cell cycle 1.9    
RNA splicing 1.8    
Noncoding RNA metabolic process /tRNA processing   4.7  
tRNA modification/wobble uridine modification   2.1  
Mitochondrion   3.4  
Macromolecular complex assembly   2.5  
Transcription regulator activity/regulation of 
transcription  8.9  3.6 
Embryonic morphogenesis  3.2   
Pattern specification process  2.4   
Cell matrix adhesion  2.7  1.9 
Extracellular matrix organization  2.2  1.6 
Positive regulation of cell migration    2.3 
Morphogenesis of a branching structure  2.4   
Tube development/lung development    2.0 
Kidney development    1.8 
Ectodermal gut morphogenesis  2.5   
Neuron cell fate commitment  2.5   
Axon guidance    1.4 
Olfactory bulb development  1.7   
Blood vessel development  2.2   
Cartilage development  1.7   
Hair cycle process/epidermis development  1.7   
Wnt signaling pathway  1.4   
hematopoietic or lymphoid organ development  1.3   
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Table 2.2. Relative enrichment (+) or under-representation (-) of specific repeat 
families in collections of ZSCAN5, RPC155, TFIIIC, and ETC ChIP peaks 
 
Repeat 
Family1 
 
ZSCAN5B 
 
ZSCAN5A 
 
ZSCAN5D 
 
RPC1552 
 
TFIIIC2 
 
ETC2 
 +/- p-value 
+
/- p-value 
+
/- p-value 
+
/- p-value 
+
/- p-value 
+
/- p-value 
tRNA + 0 + 0 + 0 + 0 + 0   
RNA + 1.4E-12     + 1.5E-02     
scRNA + 1.9E-08     + 2.9e-19 + 4.3e-02   
snRNA + 4.8E-04     + 5.3E-14     
Alu - 2.2E-08 - 4.3E-25 - 7.9E-70 + 0 + 0 + 0 
L2 - 2.3E-04   + 7.7e-10 - 1.2E-02 + 4.2e-47 + 6.4e-70 
MIR - 3.5E-03   + 1.2e-171 + 4.1E-21 + 3.1e-03 + 5.7e-04 
ERV1 - 5.0E-03 - 5.0e-04 - 2.5e-14 + 3.3E-07 - 1.8e-10 - 3.7e-06 
telo   + 7.5E-08         
Simple 
Repeat   - 4.1E-04   - 1.9E-04 + 1.9e-03   
srpRNA   + 2.3E-02   + 1.1E-03     
Gypsy   + 2.7E-02     - 4.7E-02 + 3.4E-22 
Low 
Complexity     + 4.4E-23 - 1.4E-06 + 1.5E-50   
LTR?     + 4.8E-10       
Deu       + 3.1E-02     
LTR       + 9.7E-03     
rRNA       + 0 + 0 + 1.8E-07 
RTE-BovB       + 2.2E-03     
SINE           + 2.3E-02 
1Repeat family names and locations taken from repeat masker, 
http://www.repeatmasker.org/ ; a full accounting with enrichments and depletions for 
specific elements in each family is provided in Table A.4. 
2 Peak coordinates for these feature types are taken from Moqtaderi et al., 2011, and were 
lifted over to human genome sequence build hg19.  
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CHAPTER 3: 
 
A ROLE FOR MAMMALIAN SCAN-CONTAINING ZINC FINGER 
TRANSCRIPTION FACTOR ZSCAN5A IN CELL CYCLE 
PROGRESSION 
Younguk Sun1,2, and Lisa Stubbs1,2,3 
 
ABSTRACT 
 
RNA Polymerase III (Pol III) transcription is critical for cell survival. In addition 
to its canonical roles in tRNA and ribosomal RNA synthesis, Pol III transcription is 
essential to a variety of other nuclear processes, including nucleosome positioning, global 
genome and subnuclear organization, and has direct effects on RNA pol II transcription. 
We have previously identified the ZSCAN5 transcription factor family – including 
conserved mammalian ZSCAN5B and primate-specific paralogs, ZSCAN5A and 
ZSCAN5D – as proteins that occupy Pol III promoters and extra-TFIIIC (ETC) sites 
throughout the genome. ZSCAN5 protein binding regulates expression of tRNA and 
other Pol III genes, but also affects the expression of neighboring Pol II genes involved in 
ribosome biogenesis, tRNA processing, cell cycle progression and cellular differentiation. 
Here we demonstrate that human ZSCAN5 genes are cell cycle regulated with a similar 
peak of expression around the time of mitosis, and show that the proteins display strong 
and distinct patterns of cellular localization in the dividing cells. Together with previous 
results, these data suggested an important role in chromosome segregation and mitotic 
progression, especially for ZSCAN5A. To test this hypothesis, we manipulated the levels 
of ZSCAN5A expression using stably integrated, tetracycline regulated constructs in 
cultured human cells. Consistent with an essential role in cell cycle progression 
ZSCAN5A knockdown led to the accumulation of cells in the mitotic phase and the 
appearance of aneuploid cells. These data suggest that ZSCAN5A has adopted an essential 
role in chromatin condensation and segregation in human cells, through combined action 
on Pol III transcripts and position effects on essential Pol II genes. 
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INTRODUCTION 
 
 tRNAs are encoded by RNA Polymerase III-transcribed genes that are randomly 
dispersed throughout the genomes in all eukaryotes, from the yeasts, S. cerevisiae and S. 
pombe, to mammals (Canella et al., 2010; Dittmar et al., 2006; Harismendy et al., 2003; 
Moqtaderi and Struhl, 2004; Roberts et al., 2003) . While the primary function of tRNA 
genes (tDNA) is to provide templates for the transcription of essential tRNA molecules, a 
number of studies have reported that these genes also serve a variety of “extra-
transcriptional” functions (Ebersole et al., 2011; Hull et al., 1994; Kendall et al., 2000; 
Kinsey and Sandmeyer, 1991; Raab et al., 2012). These functions have been most 
extensively investigated in yeasts, where the genes are known to congregate together at 
the nucleolus and centromeres to perform non-canonical functions (Thompson et al., 
2003; Wang et al., 2005).  
 One of the most interesting roles for tDNA is that it can serve as a heterochromatin 
barrier, that is, to prevent spreading of heterochromatin to euchromatic regions by 
repositioning nucleosomes or recruiting chromatin remodeling complex such as histone 
acetyltransferases (HATs) (Bachman et al., 2005; Donze et al., 1999; Donze and 
Kamakaka, 2001; Gelbart et al., 2005; Mertens and Roeder, 2008). Loss of this function 
was reported to result in abnormal meiotic chromosome segregation in S. pombe (Gaither 
et al., 2014) and in S. cerevisiae, suppression or deletion of tDNA loci is associated with 
abnormal expression of nearby Polymerase 2 (Pol II) genes (Haeusler et al., 2008; Wang 
et al., 2005). Pol III transcripts, and derivative elements called extra-TFIIIC (ETC) sites 
because they bind the Pol III transcription factor TFIIIC, have also been demonstrated to 
serve as insulators and chromatin organizing elements in mammalian genomes 
(Moqtaderi et al., 2010; Oler et al., 2010; Raab et al., 2012). Cohesin-interacting CTCF is 
also known to be enriched at ETCs and tDNAs with high TFIIIC and Pol III enrichment 
(Moqtaderi et al., 2010; Oler et al., 2010). 
 The expression of tRNA is regulated under many conditions, including during cell 
cycle progression and cell proliferation (Marshall and White, 2008). Most studies of Pol 
III regulation have concluded that control is mediated through TFIIIB (Marshall and 
White, 2008; White et al., 1995). It is also worth noting that 1) the relative proportions of 
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individual tRNA vary greatly in different cell types (Dittmar et al., 2006) and 2) there is 
limited overlap between the tDNAs that are occupied with Pol III in different cell types 
and tissues (Barski et al., 2010). These findings contradict previous simplistic models of 
Pol III regulation, which suggested that the genes were all expressed together, and 
suggest a more complex regulation involving a host of different TFs binding to the 
individual loci.     
In our previous study, we employed chromatin immunoprecipitation followed by 
deep sequencing (ChIP-seq) to reveal genome-wide binding of the of ZSCAN5 
transcription factor (TF) family to Pol III promoters and ETC sites (Sun et al., 2016). 
This small TF subfamily was founded by a unique, conserved member, ZSCAN5B, which 
duplicated specifically in early primate history to generate three additional TF genes. 
While all ZSCAN5 proteins bind tDNAs, ZSCAN5B exhibited the most strikingly high 
binding specificity to tRNA genes, whereas primate-specific ZSCAN5A, which is the 
dominantly expressed member of the primate family, also preferentially bound to tDNAs 
but also more widely at Pol III-related transposable elements (TEs). Furthermore, another 
primate duplicate, ZSCAN5D, displayed a high preference for a subset of TE-derived 
ETC sites. Transcriptome analysis after ZSCAN5 gene “knockdown” revealed that 
ZSCAN5A and ZSCAN5B not only regulate the expression of tRNA and other Pol III 
genes, but also modulates the expression of neighboring Pol II genes. Based on these data 
we hypothesized that ZSCAN5A and ZSCAN5B cooperatively interact in human cells, 
and that ZSCAN5A plays a particularly important role in the regulation of mitotic 
progression. This last inference was particularly intriguing, since ZSCAN5A was 
previously identified in a previous study as one of ~850 genes expressed in a cell cycle 
stage-specific pattern, with transcription peaking around the M/G1 transition (Whitfield 
et al., 2002). 
 The goal of the present study was to further investigate the potential roles of 
ZSCAN5 genes in regulating cell cycle progression with a special focus on ZSCAN5A.  
Consistent with functional predictions, we show that the human ZSCAN5 paralogs are 
cell-cycle regulated with peak expression around the time of mitosis. Using 
immunocytochemistry with antibodies specific to ZSCAN5A, ZSCAN5B, and 
ZSCAN5D, we demonstrate that the proteins display distinct patterns of cellular 
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localization that is significantly enhanced in dividing cells. A series of human cell lines 
engineered to stably carry a tetracycline-inducible transgenic allowed the manipulation of 
ZSCAN5A expression, and revealed that ZSCAN5A depletion leads to the dysregulation 
of cell cycle. More specifically, ZSCAN5A depletion leads to the accumulation of cells 
in the mitotic (M) phase and the appearance of aneuploid cells.  
These data suggest that, either through a cyto-architectural function, regulation of 
Pol III transcription, position effects on Pol II genes, or a combination of these roles, 
primate-specific ZSCAN5A has acquired a critical role in an ancient function, that is, 
maintenance of genome integrity in human cells.  
 
RESULTS 
 
Human ZSCAN5 genes display a peak of mitotic expression  
As mentioned above, ZSCAN5A was identified in a previous study as one of ~850 
genes expressed in a cell cycle stage-specific pattern, with transcription peaking around 
the M/G1 transition (Whitfield et al., 2002). To confirm this finding and to investigate the 
cell-cycle expression patterns for other ZSCAN5 genes, we synchronized HEK-293 
cultures using a double thymidine (TT) block, which synchronizes the cells at early S-
phase (Bostock et al., 1971). We collected cells at different time points after release to 
test gene expression levels of ZSCAN5A, ZSCAN5B, and ZSCAN5D by qRT-PCR, 
together with marker genes expressed at specific cell cycle stages [CCNE1 (expression 
peak at G1/S), RRM2 (S), CDC2 (G2), BUB1 (G2/M) and PTTG1 (M/G1)]. ZSCAN5B 
and ZSCAN5D showed clear peaks of expression beginning around 14 hr after 
synchronization, consistent with peak transcription during the M/G1 transition (Fig. 1). 
ZSCAN5A expression showed a similar expression pattern consistent with the published 
reports although RNA levels peaked somewhat sooner than the M/G1 transition, 
beginning around G2/M in our experiments.   
 
ZSCAN5s are differentially localized during the cell cycle 
 In yeasts, tDNA and other Pol III transcripts concentrate within subnuclear 
structures, including the nucleolus (Thompson et al., 2003; Wang et al., 2005) or the 
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mitotic spindle and centrosome (Snider et al., 2014) in budding yeast, and the nuclear 
periphery in fission yeast (Huang and Maraia, 2001). In both species, tDNAs have been 
demonstrated to interact with cohesin, which plays an important role in chromosome 
tethering throughout the cell cycle. No such distinct localization has been reported for 
tDNA or other Pol III transcripts in mammalian cells. The cellular locations of the 
ZSCAN5 proteins was therefore of interest. 
To examine the localization of ZSCAN5 proteins in mitotic cells, we used tested 
antibodies (Sun et al., 2016) along with a centrosomal marker (anti-gamma tubulin 
antibody) for immunocytochemistry. Our previous study showed robust expression of 
ZSCAN5 proteins in HEK-293 cells, and therefore we used the same cell line cultured in 
asynchronous manner to capture the cell cycle stage-specific localization of the ZSCAN5 
proteins.  
While all three ZSCAN5 proteins were detected throughout the cell cycle, a few 
noticeable localization patterns were observed. For example, during interphase, 
ZSCAN5A was concentrated in the nuclei of either recently divided cells or cells ready 
for mitotic division, indicating that ZSCAN5A expression is more pronounced during late 
G2/M transition and early G1, concordant with gene expression (Fig 3.1, Fig 3.2A). 
However, more striking concentration of the protein was found during M-phase, and 
especially anaphase. Although ZSCAN5A protein was widely distributed and not 
restricted to certain subcellular organelles during mitosis (Fig. 3.2B), ZSCAN5B was 
concentrated particularly in the centrosomal region during early to late anaphase (Fig. 
3.2C). In contrast, ZSCAN5D protein was concentrated in close proximity to the 
cleavage furrow in the late anaphase to early telophase (Fig. 3.2D). This differential 
cellular localization is remarkable as all three ZSCAN5 members exhibit similar cell 
cycle stage-specific expression (Fig. 3.1) and all three proteins bind to RNA Pol III loci 
(Sun et al. 2016). These data suggest that mammalian ZSCAN5B and its primate-specific 
paralogs may have acquired novel functions involved in cell division, and more 
specifically during mitotic division, despite their similar expression patterns and binding 
sites.  
Notably since ZSCAN5B displays a compelling preference for tDNA loci (Sun et 
al., 2016), its centrosomal co-localization is particularly interesting given previous 
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studies that have reported that tDNA co-localize with the centrosome in budding yeast 
(Snider et al., 2014). These data suggest that tDNAs are also concentrated at centrosomes 
during mitosis in mammalian cells, the first time that such a conserved localization has 
been noted in any study. 
 
ZSCAN5A knockdown increases numbers of M-phase cells and aneuploidy 
Consistent with previous reports (Whitfield et al., 2002), our data demonstrate 
that ZSCAN5 paralogs are commonly up-regulation around the time of mitosis (Fig. 3.1).  
Adding to the intrigue, ZSCAN5A knockdown experiments strongly suggested a role for 
this gene in the regulation of mitotic spindle formation, chromosome segregation and the 
metaphase/anaphase transition (Sun et al. 2016). To test this hypothesis, we transfected 
HEK-293 cells with plasmid constructs designed to express a tetracycline-regulated (Tet-
on) short hairpin RNA (shRNA), with the goal of knocking down ZSCAN5A controllably 
and stably in HEK-293 cells (ZSCAN5A-Tet-shRNA). The transfected, doxycycline 
treated cells showed significant knockdown of ZSCAN5A, as confirmed with qRT-PCR 
(approximately 85%, not shown).  
Additionally, we created versions of cell lines that conditionally overexpress 
either the full-length ZSCAN5A or ZSCAN5B open reading frame to investigate the 
dosage-dependent cellular phenotypes (ZSCAN5A-Tet-OE and ZSCAN5B-Tet-OE). 
qRT-PCR validation of these overexpression constructs after induction showed about 
10~25-fold overexpression of respective transcripts (not shown), Further analysis of these 
cells revealed phenotypes very consistent with the hypothesis that ZSCAN5A regulates 
cell cycle progression and in particular, chromosome segregation and metaphase-
anaphase transition. In contrast to cells transfected with the empty plasmid vector, 
ZSCAN5A-Tet-OE, and ZSCAN5B-Tet-OE, a significantly larger fraction of ZSCAN5A 
shRNA-expressing cells were detected at M-phase, suggesting a less rapid and efficient 
transition to anaphase (Fig. 3.3). Furthermore, flow cytometric experiments revealed that 
the appearance of aneuploidy after ZSCAN5A knockdown (Fig. 3.4), consisting of a 
population of cells with DNA content close to a haploid complement (Fig. 3.4D). These 
aneuploid cells were not detected in any of the over-expressing cells or in cells containing 
the empty plasmid vectors. Taken together with the siRNA gene expression results, these 
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data suggest that ZSCAN5A depletion leads to abnormalities in spindle assembly or 
attachment during M-phase, a situation well known to cause metaphase arrest and 
aneuploidy in mammalian cells (Musacchio, 2015). 
 
DISCUSSION 
 
Data presented here show that the ZSCAN5 subfamily of human TF genes are 
regulated during the cell cycle, with a shared pattern of up-regulation around the time of 
mitotic M-phase. ZSCAN5A appears to be activated slightly earlier than ZSCAN5B and 
ZSCAN5D, first appearing around the G2 phase, and this fact may be relevant to its 
predicted dominant effects on cell cycle progression. Together with previously reported 
analysis of differential gene expression after ZSCAN5A siRNA knockdown (Sun et al., 
2016), data presented suggest that the depletion of ZSCAN5A disrupts chromosome 
attachment or cohesion during the metaphase-anaphase transition, a situation well known 
to result in the generation of aneuploid cells (Decordier et al., 2008). Consistent with this 
interpretation, we also noted an unusual accumulation of metaphase cells after 
ZSCAN5A knockdown, suggesting a failure to pass the spindle assembly checkpoint 
(Musacchio, 2015). These results suggest that ZSCAN5A might play a more specific role 
in the maintenance of chromosome structure and integrity; through that role and due to its 
mitotic expression, the protein also impacts cell proliferation. 
The exact mechanism through which ZSCAN5A might help maintain 
chromosome integrity and during mitosis will require further study. However, previous 
studies provide some interesting clues. In particular, we have previously shown that 
either directly or through “position effects”, ZSCAN5A regulate genes required for 
mitotic progression (Sun et al., 2016); the protein may thus function simply as the 
transcriptional modulator of those essential genes. However, published data on other ZNF 
proteins also suggest that ZSCAN5A function might be more complex. For example, 
TRPS1, the gene mutated in human Tricho-Rhino-Phalangeal Syndrome, encodes a multi 
zinc finger nuclear regulator of chondrocyte proliferation and differentiation (Wuelling et 
al., 2013). Very much like the phenotype we observed after ZSCAN5A knockdown, the 
loss of Trps1 in mice led to an increased proportion of cells arrested in mitosis and 
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subsequently, to chromosome segregation defects (Wuelling et al., 2013). The Trps1 
protein was found to interact with Hdac1 and Hdac4 to increase histone deacetylation 
activity, and loss of Trps1 results in histone H3 hyperacetylation which is maintained 
during mitosis, causing impaired chromatin condensation and HP1 binding, to have cells 
accumulated in prometaphase (Wuelling et al., 2013).  
 These possibilities may be addressed in the future if the binding partners of 
ZSCAN5A in various cell contexts can be identified. For example, interactions between 
ZSCAN5A and HDACs or other predicted partners in different cell-cycle stages can be 
tested individually with co-immunoprecipitation methods, or more globally with mass 
spectrometry-based methods (Free et al., 2009). Given the known interaction of TFIIIC 
and cohesin and the importance of cohesin to maintenance of chromosome structure 
(Hakimi et al., 2002; Parelho et al., 2008), interactions between ZSCAN5 proteins and 
cohesin components could be particularly enlightening. Here is it interesting to note that 
the differentially expressed genes detected after ZSCAN5A knockdown included two loci 
encoding essential cohesion components, STAG2 and SMC3 (Sun et al., 2016), making 
these particularly interesting subjects for future study. These experiments will be major 
goals of further projects centered on the ZSCAN5 family genes. 
Together these data define unexpected functions for a conserved mammalian gene 
and two paralogs found only in primate genomes. The human paralogs have evolved from 
the basic tRNA-binding function of the conserved founder gene, ZSCAN5B, to bind more 
widely to Pol III transcripts and other TFIIIC binding sites and affect the transcription of 
a wider selection of nearby genes. Data presented here indicate that despite being 
duplicated only in primates, ZSCAN5A has been integrated into the control of a very 
ancient process, namely chromosome segregation during mitosis, and plays an important 
role in chromosome integrity. The new tools and resources I have developed (See 
Chapter 4) provide essential tools that will be needed to explore those functions in further 
depth. 
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MATERIALS AND METHODS 
 
RNA PREPARATION AND QUANTITATIVE RT-PCR 
Total RNA was isolated from cell lines and tissues using TRIzol (Invitrogen) 
followed by 30 minutes of RNase-free DNaseI treatment (New England Biolabs) at 37oC 
and RNA Clean & ConcentratorTM-5 (Zymo Research). 2 µg of total RNA was used to 
generate cDNA using Superscript III Reverse Transcriptase (Invitrogen) with random 
hexamers (Invitrogen) according to manufacturer’s instructions.  
The resulting cDNAs were analyzed of transcript-specific expression through 
quantitative reverse-transcript PCR (qRT-PCR) using Power SYBR Green PCR master 
mix (Applied Biosystems, you are supposed to say where the companies are) with 
custom-designed primer sets (Table 3.1) purchased from Integrated DNA Technology. 
Relative expression was determined by normalizing the expression of all genes of interest 
to either human or mouse Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase 
activation protein, zeta polypeptide (YWHAZ) expression (∆Ct) as described (Eisenberg 
and Levanon, 2003).   
 
CELL CULTURE AND CELL CYCLE SYNCHRONIZATION 
HEK-293 (ATCC, CRL-1573) and HEK-293 Tet-on (Clontech) cells were 
cultured in Dulbecco's Modified Eagle's Medium (DMEM) containing 2 mM L-
glutamine, 10% Tetracycline-free fetal bovine serum (FBS, Clontech), 1X Pen Strep on 
0.2% gelatin-coated flasks and incubated at 37 °C in 5% CO2. For HEK-293 cell cycle 
synchronization, 2 mM thymidine was added to HEK-293 cells grown to about 30% 
confluency and the cells were subsequently incubated for 18 hours. Thymidine was 
removed by washing with 1X PBS three times, and adding fresh media, followed by a 
further 9 hour- incubation. The second round of 2 mM thymidine was then added and 
cells were incubated for an additional 15 hours. Cells were released from G1/S to S by 
washing with 1X PBS and adding fresh media, and were collected at different time points 
thereafter (Bostock et al., 1971). 
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PLASMIDS AND TRANSFECTIONS 
To establish inducible cell lines that over-express full-length ZSCAN5A, 
ZSCAN5B, we cloned the full open reading frames of ZSCAN5A (NM_024303) and 
ZSCAN5B (NM_001080456) into Tet-inducible pTRE-Tight expression vector 
(Clontech), and named as ZSCAN5A-Tet-OE and ZSCAN5B-Tet-OE (Fig. A.1 and A.2). 
In addition, to create an inducible cell line that expresses short hairpin RNAs (shRNAs) 
targeting ZSCAN5A, annealed double-stranded oligonucleotides that encode shRNA 
sequence was cloned into the pSuperior.Puro plasmid (Oligoengine) and named as 
ZSCAN5A-Tet-shRNA (Fig. A.3). All the primers and oligonucleotides used in this study 
are described in Table 3.1. Resulting plasmids were prepared using a Plasmid Midi Prep 
kit (Qiagen) and sequenced before subsequent transfection. For plasmid DNA 
transfection, about 4.5x105 HEK-293 cells were seeded to 6-well plates 24 hours before, 
and 3 µg of each plasmid; ZSCAN5A-OE or ZSCAN5B-OE, or blank plasmid along with 
300 ng of pPur plasmid (Clontech) which confers puromycin resistance, or ZSCAN5A-
shRNA was transfected using Lipofectamine 2000 (Invitrogen). 24 hours later, 
transfected cells were selected under 1 µg/ml of puromycin for additional 14 days. Single 
colonies were selected and expanded, then tested for the efficiency of ZSCAN5A by 
qRT-PCR knockdown 48 h after addition of 1 µg/mL doxycycline (Dox; Sigma-Aldrich). 
Each colony was analyzed of it overexpression or knockdown of respective genes and 
proteins compared to Dox-treated cells carrying the empty vector. 
 
IMMUNOCYTOCHEMISTRY AND M-PHASE COUNTING 
 Stably transfected cell lines were maintained in a regular medium described above 
with the addition of 0.5 µg/ml puromycin. For immunocytochemistry (ICC), each cell 
was seeded and grown on gelatin-coated cover slips for 24 hours using the condition 
described above with or without 1 µg/ml of doxycycline. After washing with 1X PBS, 
cells were fixed with cold methanol and incubated at -20oC for 30 mins and wash three 
time with 1X PBS again. Blocking was done by incubating the coverslips with antibody 
diluent (Dako) at 4oC for 2 hours. Primary antibodies targeting ZSCAN5A (1:2000 
dilution) was custom generated by Abgent, while those targeting ZSCAN5B (Santa Cruz 
Biotechnology, 1:2000 dilution), ZSCAN5D (Aviva, 1:2000 dilution) are described in 
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detail and were validated in our previous study (Sun et al., 2016). Anti-Gamma-tubulin 
(Abcam, 1:5000 dilution), and anti-Phospho-Histone H3 (Ser10) (EMD Millipore, 1:5000 
dilution) were purchased from the above named companies. Secondary antibodies 
targeting primary antibodies were either conjugated with Alexa Fluor® 568 (1:5000 
dilution) or Alexa Fluor® 488 (1:5000 dilution) and purchased from Thermo Scientific. 
Mounting was done using ProLong® Gold Antifade Mountant with DAPI (Thermo 
Scientific) and confocal microscopy imaging was done using confocal microscope Zeiss 
LSM880 in the Institute for Genomic Biology Core Facility at the University of Illinois at 
Urbana-Champaign. More than 10 random images from each sample were processed and 
counted of total and mitotic cells using ImageJ software (Schneider et al., 2012). 
 
FLOW CYTOMETRY 
 In order to measure the effects of ZSCAN5 on G1/S/G2 distribution, flow 
cytometry was done using above described transgenic cell lines stained with propidium 
iodide. Cells were grown as described above with 1 µg/mL Dox for 48 hours. Each 
sample was trypsinized using 0.25% trypsine/EDTA (Gibco) and washed with 1X PBS 
with 0.2% FBS. Cell pellets were fixed with cold ethanol and stored at -20oC for 24 
hours. Fixed cells were washed twice with 1X PBS and stained with FxCycle™ PI/RNase 
Staining Solution (Thermo Scientific) at room temperature for 30 minutes. BD LSRII 
Flow cytometry analyzer was used at the Flow Cytometry facility at the University of 
Illinois at Urbana-Champaign and resulting data were processed and analyzed using FCS 
Express 5 software. 
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FIGURES 
Figure 3.1. 
  
 
 
 
 
 
 
 
 
 
  2h 6h 10h 14h 18h 22h 
ZSCAN5A 475.65 490.855 723.315 695.06 690.885 374.59 
ZSCAN5B 25.595 34.48 36.125 59.69 41.675 22.26 
ZSCAN5C 8.875 18.62 12 18.025 22.675 9.21 
ZSCAN5D 99.605 106.95 118.43 151.965 108.4 71.235 
CCNE1 6762.175 5984.81 4737.2 5808.575 5270.755 7847.29 
RRM2 39861.63 64851.08 36734.89 32082.56 34015.94 29267.47 
CDC2 5326.05 7918.475 13412.69 13568.86 6124.265 6173.055 
BUB1 16037.34 25008.09 38027.1 57032.77 23263.43 13312.39 
PTTG1 10868.12 15055.15 23568.57 30041.94 30999.69 16495.17 
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Figure 3.1. (cont.) Cell cycle stage-specific expression ZSCAN5 family genes  
Heat map was created based on the expression value (table) acquired from qRT-PCR of 
time-series sample collections of HEK-293 cells after the release from double thymidine 
blocks (see methods). Expression levels of CCNE1, RRM2, CDC2, BUB1 and PTTG1 
were measured on the same cDNA samples to monitor progression through the cell cycle. 
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Figure 3.2.          
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Figure 3.2. (cont.) Differential cellular localization of ZSCAN5 during cell cycle 
HEK-293 cells were grown on glass cover slips and fixed, stained with anti-gamma-
tubulin and respective anti-ZSCAN5 antibodies. (A) Selective localization of ZSCAN5A 
(Alexa Fluor® 568: red) in dividing cells. (B) Dispersed localization of ZSCAN5A 
(Alexa Fluor® 568: red) during anaphase. (C) Co-localization of ZSCAN5B (Alexa 
Fluor® 568: red) and centrosome (Alexa Fluor® 488: green, arrowheads) during 
anaphase. (D) Concentration of ZSCAN5D (Alexa Fluor® 568: red) in the cleavage 
furrow (arrowhead) in late anaphase. White scale bar corresponds to 10 µm.                        
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Figure 3.3.         
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Figure 3.3. (cont.) ZSCAN5A knockdown increases numbers of M-phase cells Stably 
transfected doxycycline-inducible HEK-293 cell lines overexpressing full-length 
ZSCAN5A (ZSCAN5A-Tet-OE), ZSCAN5B (ZSCAN5B-Tet-OE) or expressing short 
hairpin RNA targeting ZSCAN5A (ZSCAN5A-Tet-shRNA), or mock transfection 
control were incubated with 1 µg/mL doxycycline for 48 hours on gelatin-coated glass 
cover slips. Fixed coverslips were stained with mitotic marker anti-Phospho-Histone H3 
(Ser10) antibody, and DAPI to visualize mitotic cells using microscopy. Resulting image 
was processed and counted of total nuclei and mitotic nuclei using ImageJ software 
(REF). The proportion of anti-Phospho histone 3 (anti-pH3) positive nuclei or mitotic 
nuclei out of counted total nuclei after doxycycline induction (Dox+) in mock 
transfection control was set to 100%. Error bars indicate standard errors for each sample 
(𝑆𝑆𝑆𝑆 = ��𝑜𝑜(1−𝑜𝑜)
𝑐𝑐
�, where p, proportion of mitotic nuclei, n, total number of nuclei 
stained). Asterisk refers to statistical significance.                      
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Figure 3.4.   
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Figure 3.4. (cont.) Knockdown of ZSCAN5A result in small subset of cells with low 
DNA content  
Flow cytometry was done on inducible transgenic HEK-293 cells stably transfected with 
(A) mock plasmid control, (B) ZSCAN5A overexpression plasmid (ZSCAN5A-Tet-OE), 
(C) ZSCAN5B overexpression plasmid (ZSCAN5B-Tet-OE), (D) ZSCAN5A shRNA 
plasmid (ZSCAN5A-Tet-shRNA) were cultured for 48 hours with addition of 1µg/mL 
doxycycline. Black arrowheads indicate a small population of cells with lower DNA 
content compared to normal G1 cells.                        
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TABLE 
 
Table 3.1. Primers and oligonucleotides used in this study 
Gene 
expression 
primers 
DNA sequence (5'>>3') Amplicon size Description 
ZSCAN5A-F ACACAAGAGTATTGACGTAACAGGTGA 498 human ZSCAN5A (Tm: 60.6oC) 
ZSCAN5A-R GCTTGGAATTACACGTAAACCTCTTCTCG  human ZSCAN5A (Tm: 62.2oC) 
ZSCAN5B-F AAGAGTCCCACAGATCTGGTGAG 388 human ZSCAN5B (Tm: 59.7oC) 
ZSCAN5B-R TGCTTAGCTGGGAAAAATACTTAAATGATTTATTG  
human ZSCAN5B 
(Tm: 61.1oC) 
ZSCAN5C-F TTCCAAACAGTCCCACAGGGG 468 human ZSCAN5C (Tm: 60.6oC) 
ZSCAN5C-R CATGCAGCGCATAGGCCTG  human ZSCAN5C (Tm: 59.6oC) 
ZSCAN5D-F CTGTGGTCAATTTTCTTGGCAAGGA 367 human ZSCAN5D (Tm: 60.4oC) 
ZSCAN5D-R CCCACCACACCTGTAGGACC  human ZSCAN5D (Tm: 60.1oC) 
hYWHAZ-F ACTTTTGGTACATTGTGGCTTCAA 95 human internal reference control  
hYWHAZ-R CCGCCAGGACAAACCAGTAT  human YWHAZ (Tm: 58oC) 
    
Cloning 
primers DNA sequence (5'>>3') Tm   
ZSCAN5A-
Tet-OE-F 
NNNNN-GGATCC-GCCACC 
ATGGCTGCAAATTGCACATCCTC 60 
5’overhang-BamHI-
Kozak-DNA 
sequence 
ZSCAN5A-
Tet-OE-R 
NNNNN GCGGCCGC 
CTGAGAAGTAGCTTCTGGATG TGTTTTC 60 
5’overhang-NotI-
DNA sequence 
ZSCAN5B-
Tet-OE-F 
NNNNN-GAATTC-GCCACC 
ATGGCTGCAAATTGCACATCCTC 60 
5’overhang-EcoRI-
Kozak- DNA 
sequence 
ZSCAN5B-
Tet-OE-R 
NNNNN GCGGCCGC 
CTGGGAGGTGGTTTCCCG 60  
    
 
ZSCAN5A shRNA oligonucleotide sequences 
5’ – BglII – sense – hairpin – antisense – XhoI – 
3’  
Size  
ZSCAN5A-
Tet-shRNA-
sense 
GATCCCCGAGAAGAGGTTTACGTGTATT
CAAGAGATACACGTAAACCTCTTCTCTTT
TTA 
60 
siRNA Cat. # 
(Qiagen): 
SI00779436 
ZSCAN5A-
Tet-shRNA-
antisense 
TCGATAAAAAGAGAAGAGGTTTACGTGT
ATCTCTTGAATACACGTAAACCTCTTCTC
GGG 
60  
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CHAPTER 4: 
 
TOOLS AND RESOURCES FOR ANALYSIS OF  
BIOLOGICAL FUNCTIONS OF MOUSE Zscan5b 
Younguk Sun1,2, and Lisa Stubbs1,2,3 
 
ABSTRACT 
 
The results presented in this thesis suggest an important role for the conserved 
gene ZSCAN5B and its primate-specific paralogs in the regulation of transcription of 
RNA Polymerase III (Pol III) loci as well as neighboring Pol II genes. Gene knockdown 
and genetic manipulation experiments have indicated that human ZSCAN5A plays an 
essential role in mitotic progression and chromosome integrity, and suggested similar and 
cooperative functions for ZSCAN5B. Gene knockdown experiments and in vivo 
expression data also suggested that the ZSCAN5 genes play a role in differentiation 
decisions in a number of tissues. Together these data suggest a number of intriguing 
hypotheses for future studies that will require the development of specialized resources.   
In this chapter, I will describe the generation of some essential tools, including 
expression constructs and two sets of transgenic mouse lines that I have already 
developed for this purpose. I also outline ideas for experiments, some of which are 
already underway, that can use these resources to address the root biological functions of 
the ZSCAN5 family through analysis of the unique mouse family member, Zscan5b. 
 
 
 
 
1 Institute for Genomic Biology  
2 Department of Cell and Developmental Biology,  
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INTRODUCTION 
  
This thesis has focused on the unique eutherian gene, ZSCAN5B, which 
duplicated to give rise to clustered paralogs, ZSCAN5A, ZSCAN5C and ZSCAN5D, in 
early primate history. In a previous chapter (Chapter 2), I showed that three of the 
primate genes, ZSCAN5A, B, and D, are expressed in different human tissues and are 
robustly expressed in rapidly dividing cell populations. I also showed that the ZSCAN5 
proteins bind preferentially to RNA Polymerase III (Pol III) transcription units, especially 
tDNAs, and related repetitive elements. ZSCAN5B protein binds with high specificity to 
a particular subset of tDNA sequences in two human cell lines, and to the same subset of 
conserved tDNA in mouse fetal placenta. Furthermore, ZSCAN5A and ZSCAN5D also 
occupy RNA Polymerase III (Pol III) promoters as well as extra-TFIIIC (ETC) sites 
throughout the genome.  
Combining ChIP-seq data with the analysis of global gene expression after 
ZSCAN5 gene knockdown, I showed that ZSCAN5 protein binding not only regulates 
expression of the bound Pol III genes, but also affects the expression of neighboring Pol 
II genes implicated in ribosome biogenesis, tRNA processing, cell cycle progression and 
cellular differentiation. In particular, gene expression data implicated ZSCAN5A for a 
role in chromosome segregation and in Chapter 3, I further investigated this hypothesis 
by manipulating the levels of ZSCAN5A expression in mammalian cells. Consistent with 
an essential role in cell cycle progression, ZSCAN5A knockdown led to the accumulation 
of cells in the mitotic M-phase and the appearance of aneuploid cells. Since gene 
expression and ChIP data also suggested that ZSCAN5B cooperates with ZSCAN5A in 
regulating cell cycle regulation and differentiation (Chapter 2), it follows that the 
conserved mouse gene might play a similar role. 
In this chapter, I describe the development tools to further investigate the 
biological roles of the ancestral Zscan5b in the mouse model system, including inducible 
overexpression and shRNA plasmid constructs. These constructs have been used to 
establish stable cell lines and importantly, transgenic mouse lines that will allow future 
investigations of the developmental roles of Zscan5b and the effects of gene knockdown 
or overexpression on mouse health, fertility and behavior. 
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RESULTS 
 
TOOLS FOR FURTHUR STUDY 
 
Inducible overexpression of mouse Zscan5b, mZscan5b-Tet-OE 
 My first goal was to generate constructs to allow the expression of the Zscan5b 
protein in mouse cells and transgenic mice. From data reported in Chapters 2 and 3, I 
reasoned that these expression constructs should be inducible rather than constitutively 
expressed, in order to prevent any possible negative effects on cell maintenance and 
transgenic animal viability. I therefore chose the tetracycline-inducible (Tet-on) system to 
generate these expression constructs (Gossen et al., 1995). 
The pTRE-Tight vector is designed with a tetracycline response element (TRE) 
promoter that is tightly regulated but highly inducible in the presence of Doxycycline 
(Dox), and a SV40 poly-A signal for a stable translation. I further modified this plasmid 
to incorporate two STREP-tag II (WSHPQFEK) (Korndorfer and Skerra, 2002) and three 
hemagglutinin tags (HA: YPYDVPDYA) (Wilson et al., 1984) to the C-terminus of the 
protein of interest and named “pTTS2.1”. The tags are incorporated into the expressed 
protein to provide a tool for efficient detection and purification, as described in more 
detail the Discussion.   
This pTRE-Tight plasmid can overexpress the cloned gene only in the presence of 
reverse Tet Trans-Activator (rtTA) protein and Dox (Gossen et al., 1995). In order to 
investigate the biological functions of the mouse version of Zscan5b (mZscan5b 
hereafter) as they relate to cellular functions and differentiation, I created a Tet-inducible 
plasmid construct capable of overexpressing the open reading frame of full-length 
mZscan5b. After thorough validation of its DNA sequences, the resulting plasmid was 
named “mZscan5b-Tet-OE”, purified and stored for the downstream experiments such 
mammalian cell transfections and transgenic mouse line establishment.   
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Inducible small hairpin RNA (shRNA) targeting mZscan5b, mZscan5b-Tet-shRNA 
 In contrast to the inducible overexpression plasmid construct described above, I 
also created a version of inducible plasmid that conditionally expresses shRNA upon Dox 
induction in order to assess the phenotypic difference compared to mZscan5b-Tet-OE. As 
effective the gene ablation using siRNA treatment as it may be, the treatment has its 
drawback due to the instability of the siRNA and thus short duration of knockdown, 
making it unsuited to evaluate the long-term consequences of transcript depletion. I used 
an inducible shRNA plasmid with embedded mammalian selective marker, 
pSuperior.Puro (Oligoengine), enabling its stable incorporation into genome for later 
experiments (Brummelkamp et al., 2002a, b). The insert shRNA sequence was based on 
the siRNA sequence that was most efficient at mZscan5b knockdown among a set of 
three siRNA designs (purchased from Qiagen, Inc.; data not shown). This plasmid was 
named “mZscan5b-Tet-shRNA”, and thoroughly sequenced and purified for further 
experimentation. 
 
Transfection with mZscan5b-Tet-OE and mZscan5b-Tet-shRNA to mouse cell lines 
 Cloned and purified plasmids were initially tested by transfection to the Neuro2a 
Tet-on cell line, a modified mouse neuroblastoma cell line that constitutively expresses 
rtTA (Clontech). Transfected cells were selected under puromycin for 14 days and 
individual colonies were subcultured to establish stably transfected cell lines. Each 
colony was genotyped and analyzed for transgene induction efficiency, or for the 
efficiency of mZscan5b knockdown after Doxycycline (Dox) treatment compared to 
uninduced cells or vector-only transfected controls. Transcript level analysis was done 
using qRT-PCR, and mZscan5b protein expression was measured using Western blots. 
This transfection analysis was used as an intermediary testing platform to validate the 
Tet-inducibility for the next step, the establishment of transgenic mice. 
 
Generation of transgenic mice overexpressing and knocking down mZscan5b 
The investigation of biological functions of mZscan5b in vivo is our paramount 
interest. To enable this investigation, the functional fragments of the plasmid including 
the Tet-regulatable promoter, the Strep-and HA-tagged mZscan5b open reading frame, 
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and the SV40 poly-A signal DNA sequence from the mZscan5b-Tet-OE plasmid was 
cleaved, gel isolated and employed to create transgenic mouse lines that can conditionally 
overexpress mZscan5b.  
At the same time, the mZscan5b-Tet-shRNA plasmid was also linearized to make 
another set of transgenic mouse lines able to express the shRNA targeting mZscan5b 
upon Dox induction. Both constructs were injected into wild type mice oocytes at the 
Transgenic Mouse Facility at University of Illinois at Urbana-Champaign. Initial 
screening was done by tail-snip genotyping of pups from a number of transgenic founders 
of both sets of lines: mZscan5b overexpression mice (mZ5b-FL) and mZscan5b shRNA 
mice (mZ5b-sh).  
For mZ5b-FL, only 1 out of 37 male mice and 8 out of 32 female mice were 
positive for transgene incorporation, while 4 out of 27 male mice and 5 out of 17 female 
mice showed strong positive signals for mZ5b-sh. Each positively selected male mouse 
was then bred with wildtype females to yield offspring and to establish transgenic lines 
from several founders. These lines are now ready for testing, as described below.  
   
DISCUSSION 
 
As described, I have generated tetracycline inducible over-expression and shRNA 
constructs to study the functions of Zscan5b in the mouse model system. These inducible 
protein constructs offer several advantages that we can now employ in studies of 
mZscan5b function. First, we can culture cells or breed mice without expressing the 
transgene, then induce their expression by adding Dox to the culture medium or feeding 
the animals Dox. In Tet-on transgenes, protein or shRNA expression is proportional to 
the concentration of Dox administered (Seibler et al., 2007). This fact enable us to “fine 
tune” the dosage of mZscan5b in the cell lines or mice.  
Second, our constructs are designed to attach widely used peptide tags to the 
proteins, Strep-tag II and HA, that can be detected with commercially available, high-
specificity antibodies; this creates an opportunity for follow-on experiments of several 
types. For example, we are interested in identifying cellular binding partners for Zscan5b, 
and these tags will allow for very efficient methods of protein isolation, and for more 
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complex protocols like co-immunoprecipitation followed by mass spectroscopy (Free et 
al., 2009). We were able to generate an antibody targeting mZscan5b and use it for 
Chromatin immunoprecipitation (Chapter 2), but this antibody did not show the type of 
high affinity we can expect from anti-HA or anti-FLAG reagents.  
Furthermore, purification of C2H2 zinc finger proteins in E. coli has been a huge 
challenge, due to the nature of cysteine-cysteine disulfide bridges which leads to the 
proteins being retained in inclusion bodies after overexpression (Yan and Sun, 2009). For 
that reason, expression and purification of transgene in a mammalian cell line, which is 
already equipped with proper protein folding or re-folding machinery such as molecular 
chaperones, has been an alternative and preferred solution (Hurt et al., 2003). Purification 
of mZscan5b proteins after mammalian expression will be facilitated by the Strep-tag II, 
owing to its high-specificity. The purified protein can then be used to determine the 
binding affinity or specificity to certain DNA sequences using electrophoretic mobility 
shift assay (EMSA) or other protein partners in vitro. 
Most importantly, the transgenic mice I have generate provide new an important 
resources for the Stubbs laboratory, which can be used in a number of future studies. A 
few of these experiments are already underway. For example, female transgenic mice 
have been bred to male animals carrying a constitutive rtTA gene inserted into the 
ROSA-26 locus (Gt(ROSA)26Sortm1(rtTA*M2)Jae/J; from The Jackson Laboratory) 
(Hochedlinger et al., 2005). If a transgenic female is crossed to a male ROSA-rtTA 
homozygous male and fed Dox during pregnancy, the mZscan5b transgenes will be 
activated in 50% of her pups (the pups inheriting both mZscan5b and rtTA transgenes). 
These experiments will allow us to assess the role of Zscan5b on mouse development. 
Since the Dox can be administered at different times during pregnancy, we can also target 
certain stages of development. 
 Another set of experiments, now underway, will test the role of mZscan5b in 
mouse fertility. As described in Chapter 2, mZscan5b is very highly expressed in testis 
and IHC studies have shown that the protein is present in developing germ cells. To test 
the role in germ cell differentiation, we are treating males with the mZscan5b and ROSA-
rtTA transgenes with Dox postnatally and examining the progression of spermatogenesis.   
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 These resources thus allow us to investigate the biological functions of mouse 
Zscan5b both during development and in adult tissues. These new studies will permit us 
to place the regulation of tDNA, Pol III transcripts, and neighboring genes in the context 
of development and tissue maintenance in vivo. 
 
MATERIALS AND METHODS 
 
PLASMIDS AND CLONING 
 
Modification of Tet-inducible overexpression plasmid, pTTS2.1 
The pTRE-Tight vector was purchased from Clontech (Cat. 631059). For added 
functionality, two STREP-tag II (WSHPQFEK) and three hemagglutinin (HA: 
YPYDVPDYA) tags were incorporated to the 3’ of multiple cloning sites. To do this, 
150-mer of sense and antisense oligonucleotides which encode aforementioned peptide 
tags flanked by restriction enzyme sites, XbaI, were ordered from Integrative DNA 
Technology (Table 4.1). 2 µg of each oligonucleotide was mixed in the annealing buffer ( 
10 mM Tris-HCl pH8.0, 50 mM NaCl, 1 mM EDTA) and heated up to 95oC for 10 mins 
in a heat block. The heated block was left out at room temperature to slowly cool down to 
anneal two oligonucleotides. The annealed double stranded DNA was then ligated to 
XbaI-digested pTRE-Tight plasmid. Cloned plasmid was sequenced to verify correct 
insertion and purified for later experiments. The resulting plasmid was named as 
“pTTS2.1” plasmid. All primers and oligonucleotides used in this chapter are described 
in Table 4.1. Restriction enzymes and T4 DNA ligase were purchased from New England 
Biolabs and Pfx High-fidelity PCR DNA polymerase was purchased from Life 
Technology. PCR purification kit and Plasmid Mini-/Midi- preparation kits were 
purchased from Qiagen. 
 
Construction of Tet-inducible overexpression plasmid, mZscan5b-Tet-OE 
In order to clone the open reading frame (ORF) of mZscan5b, testis cDNA from 
C57BL6/J mouse was obtained and used as a PCR template to generate mZscan5b ORF 
insert DNA flanked by EcoRI (5’) and NotI (3’) restriction sites using Pfx High-fidelity 
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DNA polymerase (Life Technology) and primers (Table 4.1). The resulting PCR 
amplicon was purified, digested with EcoRI and NotI, and ligated to double-digested 
pTTS2.1 plasmid. After the validation the DNA sequences, plasmids were purified from 
E. coli using a Midi-prep Plasmid Purification system (Qiagen Cat. 12145), then labeled 
as “mZscan5b-Tet-OE”.   
 
Construction of Tet-inducible shRNA plasmid, mZscan5b-Tet-shRNA 
 To create an inducible cell line that expresses short hairpin RNAs (shRNAs) 
targeting mZscan5b, an annealed double stranded oligonucleotides that encode shRNA 
sequence was cloned into the pSuperior.Puro plasmid (Oligoengine) and named as 
“mZscan5b-Tet-shRNA” 
 
CELL CULTURE AND DNA TRANSFECTION 
Neuro2a Tet-on (Clontech) cells were cultured in Dulbecco's Modified Eagle's 
Medium (DMEM) containing 2 mM L-glutamine, 10% Tetracycline-free fetal bovine 
serum (FBS, Clontech), 1X Pen Strep on 0.2% gelatin-coated flasks and incubated at 37 
°C in 5% CO2. For plasmid DNA transfection, about 4.5x105 Neuro2a Tet-on cells were 
seeded to 6-well plates 24 hours before, and 3 µg of each plasmid; mZscan5b-Tet-OE, or 
blank plasmid along with 300 ng of pPur plasmid (Clontech) which confers puromycin 
resistance, or mZscan5b-Tet-shRNA was transfected using Lipofectamine 2000 
(Invitrogen). 24 hours later, transfected cells were selected under 1 µg/ml of puromycin 
for additional 14 days. Single colonies were selected and expanded, then tested for the 
efficiency of ZSCAN5A by qRT-PCR knockdown 48 h after addition of 1 µg/mL 
Doxycycline (Dox; Sigma-Aldrich). Each colony was analyzed of it overexpression or 
knockdown of respective genes and proteins compared to Dox-treated cells carrying the 
empty vector. 
 
RNA PREPARATION AND QUANTITATIVE RT-PCR 
Total RNA was isolated from cell lines and tissues using TRIzol (Invitrogen) 
followed by 30 minutes of RNase-free DNaseI treatment (New England Biolabs) at 37oC 
and RNA Clean & ConcentratorTM-5 (Zymo Research). 2 µg of total RNA was used to 
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generate cDNA using Superscript III Reverse Transcriptase (Invitrogen) with random 
hexamers (Invitrogen) according to manufacturer’s instructions.  
The resulting cDNAs were analyzed of transcript-specific expression through 
quantitative reverse-transcript PCR (qRT-PCR) using Power SYBR Green PCR master 
mix (Applied Biosystems, you are supposed to say where the companies are) with 
custom-designed primer sets (Table 3.1) purchased from Integrated DNA Technology. 
Relative expression was determined by normalizing the expression of all genes of interest 
to either human or mouse Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase 
activation protein, zeta polypeptide (YWHAZ) expression (∆Ct) as described (Eisenberg 
and Levanon, 2003).   
 
PROTEIN PREPARATION AND WESTERN BLOTS 
Nuclear Extracts were prepared with NucBusterTM Protein Extraction Kit 
(Novagen) and measured by Bradford-based assay (BioRad). The extracts were stored at 
-80oC and thawed on ice with the addition of protease inhibitor Cocktail (Roche) directly 
before use. 15 µg of nuclear extracts were run on 10% acrylamide gels and transferred to 
hydrophobic polyvinylidene difluoride (PVDF) membrane (GE-Amersham, 0.45 µm) 
using BioRad Semi-dry system, then visualized by exposure to MyECL Imager (Thermo 
Scientific).  
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FIGURES 
Figure 4.1. DNA sequence and plasmid map of Doxycycline-inducible mZscan5b 
overexpression construct, mZscan5b-Tet-OE  
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Figure 4.1. (cont.) 
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Figure 4.2. DNA sequence and plasmid map of Doxycycline-inducible mZscan5b 
shRNA construct, mZscan5b-Tet-shRNA  
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Figure 4.2. (cont.) 
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TABLE 
 
Table 4.1. Primers and oligonucleotides used in this study 
Oligonucleotides DNA sequence (5'>>3') Amplicon size Description 
pTTS2.1 Tag sense 
CTAGA-C-GGT-GCA-
TGGAGCCACCCGCAGTTCGAAAAG-
TGGAGCCACCCGCAGTTCGAAAAG- 
-GGT-GCA-
TACCCATACGATGTTCCAGATTACGCT-
TACCCATACGATGTTCCAGATTACGCT-
TACCCATACGATGTTCCAGATTACGCT- 
TAA-T 
150 
XbaI-Gly-
Ala-Strep-
Strep- 
Gly-Ala-
HA-HA-
HA-STOP 
pTTS2.1 Tag antisense 
TCTAGATTAAGCGTAATCTGGAACATCGTA
TGGGTAAGCGTAATCTGGAACATCGTATGG
GTAAGCGTAATCTGGAACATCGTATGGGTT
GCACCCTTTTCGAACTGCGGGTGGCTCCACT
TTTCGAACTGCGGGTGGCTCCATGCACCG 
150  
    
 mZscan5b shRNA oligonucleotide sequences 5’ – BglII – sense – hairpin – antisense – XhoI – 3’  Size  
mZscan5b-Tet-
shRNA-sense 
GATCCCCAAGAAGAGCTTTCTTTACATTCAA
GAGATGTAAAGAAAGCTCTTCTTTTTTTA 60 
siRNA Cat. 
# (Qiagen): 
SI01489226 
mZscan5b-Tet-
shRNA-antisense 
TCGATAAAAA AAGAAGAGCTTTCTTTACA 
TCTCTTGAATGTAAAGAAAGCTCTTCTTGGG 60  
    
Cloning primers DNA sequence (5'>>3') Tm   
mZscan5b-Tet-OE-F NNNNN-GAATTC-GCCACC ATGGCTACGAATGTGCCGCC 61.3 
5’overhang-
EcoRI-
Kozak-DNA 
sequence 
mZscan5b-Tet-OE-R NNNNN GCGGCCGC TCAGACACCTTTCTCTTTCTCAGGTG 60.7 
5’overhang-
NotI-DNA 
sequence 
    
Genotyping primers DNA sequence (5'>>3') Tm   
mZ5b-FL-F TGCAGGGCCACAGTCGAG 60 mZ5b-FL genotype 
mZ5b-FL-R CATCGTATGGGTACTTTTCGAACTGC 60.3 mZ5b-FL genotype 
mZ5b-sh-F CATCAACCCGCTCCAAGGAATC 59.6 mZ5b-sh genotype 
mZ5b-sh-R AATGTGAGTTAGCTCACTCATTAGGC 59.4 mZ5b-sh genotype 
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CHAPTER 5: 
 
CONCLUSIONS AND SUMMARY 
 
This thesis has focused on the unique eutherian gene, ZSCAN5B, its primate-
specific paralogs, ZSCAN5A, ZSCAN5C and ZSCAN5D. In Chapter 2, I have shown that 
the genes duplicated in early primate history and diverged quickly in their DNA-binding 
“fingerprint” patterns, but have been conserved in sequence since that early divergence.  
While I could find no tissue or cell line in which ZSCAN5C is expressed, the high level 
of conservation of this paralog in primates suggests that it likely does have a function in 
limited cell types, tissues, or conditions that were not explored here. The three primate 
paralogs, ZSCAN5A, B, and D, that are expressed show different human tissue-specific 
patterns of expression, but overlap in many tissues and are robustly expressed in tissue 
with rapidly dividing cell populations. Using in situ hybridization, I showed that 
ZSCAN5B is expressed within the dividing cell population in those tissues, and that the 
mouse homolog, Zscan5b, is widely expressed in dividing cells in embryogenesis.   
Using chromatin immunoprecipitation (ChIP-seq), I also showed that all three 
expressed ZSCAN5 proteins bind preferentially to Pol III transcription units, especially 
tDNAs, and related repetitive elements. ZSCAN5B binds with high specificity to a 
particular subset of tDNA sequences in two human cell lines, and Zscan5b binds to the 
same conserved subset in mouse tissues. Primate-specific paralogs ZSCAN5A and 
ZSCAN5D also occupy tDNAs and other RNA Polymerase III (Pol III) promoters, but 
ZSCAN5D showed a special preference for LINE2 and MIR SINE-associated extra-
TFIIIC (ETC) sites throughout the genome. Combining ChIP-seq and RNA-seq data after 
ZSCAN5 gene knockdown, I provided evidence to suggest that ZSCAN5B protein 
binding not only regulates expression of Pol III genes, but also affects the expression of 
neighboring Pol II genes implicated in ribosome biogenesis, tRNA processing, cell cycle 
progression and cellular differentiation.   
In Chapter 3, I further investigated the hypothesis that human ZSCAN5s are 
involved in cell cycle progression by manipulating the level of expression in mammalian 
cells. Consistent with an essential role in cell cycle progression ZSCAN5A knockdown 
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led to the accumulation of cells in the mitotic M-phase and the appearance of aneuploid 
cells. In Chapter 4, I describe the development tools to further investigate the biological 
roles of the ancestral Zscan5b in the mouse model system, including inducible 
overexpression and shRNA plasmid constructs. These constructs have been used to 
establish stable cell lines and importantly, transgenic mouse lines that will allow future 
investigations of the developmental roles of Zscan5b and the effects of gene knockdown 
or over-expression on mouse health, fertility and behavior. 
Taken together, these studies suggest that ZSCAN5B arose in eutherian species to 
modulate the very ancient process of tRNA synthesis, and with it very likely, the most 
ancient mechanism of three-dimensional chromatin organization. The three additional 
family members added in early primate lineages have retained a preference for Pol III 
transcript binding, and our data indicate that the dominantly expressed human paralog, 
ZSCAN5A, acts cooperatively with ZSCAN5B. Together these proteins appear to impact 
cell division and differentiation in a wide variety of developing and adult cells. 
As we highlight in Chapter 2, one of the direct targets of ZSCAN5A and 
ZSCAN5B cooperative binding is RMRP, a gene encoding the RNA component of 
RNase P, and many ZSCAN5-regulated genes– from ribosome biogenesis and tRNA 
processing to cell cycle regulation – could possibly be explained as downstream effects 
on this single Pol III target gene. However dysregulation of tRNA expression, or effects 
on the flanking Pol II genes, almost certainly play a role.   
With present data, we cannot be certain about the mechanisms through which 
ZSCAN5 proteins regulate either the Pol III genes themselves, or the flanking Pol II 
genes. Published data from other groups suggest that the Pol II genes may be 
dysregulated simply as a secondary effect of the modulation of Pol III transcripts. And it 
seems clear that modulating Pol III gene activity should have direct effects on three-
dimensional chromatin structure. Future studies, including the application of techniques 
to measure changes in chromatin architecture, as well as co-immunoprecipitation (co-IP) 
analysis to query potential binding partners of the proteins throughout the cell cycle, will 
allow us to gain mechanistic information about the ZSCAN5 genes and their regulatory 
functions in mammalian cells.  
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APPENDIX: SUPPLEMENTAL TABLES AND FIGURES 
 
Table A.1. Analyses of affected ZSCAN5 family transcript expression level after 
specific ZSCAN5 gene ablation 
qRT-PCR was done to measure the level of cross-reactivity among ZSCAN5 family after 
individual siRNA treatments (see methods). Standard deviations were measured from 
experimental triplicates.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ZSCAN5A (%) STDEV   
ZSCAN5B 
(%) STDEV   
ZSCAN5D 
(%) STDEV 
HEK ZSCAN5A 
si4 28.4 5.5  
HEK ZSCAN5A 
si4 148.7 13.4  
HEK ZSCAN5A 
si4 59.0 9.1 
HEK ZSCAN5A 
si5 27.4 3.0  
HEK ZSCAN5A 
si5 95.3 29.8  
HEK ZSCAN5A 
si5 46.4 4.6 
HEK ZSCAN5B 
si1 106.2 3.9  
HEK ZSCAN5B 
si1 23.1 6.0  
HEK ZSCAN5B 
si1 73.7 13.4 
HEK ZSCAN5D 
si2 92.6 1.9  
HEK ZSCAN5D 
si2 147.2 9.5  
HEK ZSCAN5D 
si2 32.4 16.2 
HEK Sc Ctrl 100.0 8.7  HEK Sc Ctrl 100.0 7.9  HEK Sc Ctrl 100.0 17.5 
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Table A.2. Combined data from RNA-seq and ChIP-seq experiments merged and 
organized by chromosome location  
ChIP peaks were determined using MACS software, except for 5B_HEK293-Homer 
peaks which were determined using HOMER software, as described in Methods. Overlap 
with Oler et al. 2010-Multiple cell type (=OM) or Moqtaderi et al., 2010 RPC155 (R), 
TFIIIC(T) or ETC(ETC) peaks. Original data table contains more than 4,800 rows. Due 
to page limitation, only the first page is shown below. 
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Table A.3. Densitometric analyses of affected ZSCAN5 family protein expression 
level after specific ZSCAN5 gene ablation  
After siRNA knockdown, resulting Western Blot was processed and analyzed with 
ImageJ software to quantitatively evaluate the knock down rates in protein level. Signal 
intensity values of internal control (TBP) of each sample was used to normalize and 
calculate the % expression after gene ablation.           
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Samples density 
TBP control 
density 
Normalization  
against TBP control % Expression 
ZSCAN5A si 1324.77 21704.903 0.061035518 15.87 
Sc ctrl 9050.255 23533.731 0.384565244  
ZSCAN5B si 3401.79 20085.388 0.169366407 32.97 
Sc ctrl 9608.154 18705.702 0.513648405  
ZSCAN5D si 1718.841 25027.711 0.068677515 19.93 
Sc ctrl 8346.912 24229.468 0.344494233  
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Table A.4. Element repeat overlap summary 
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Table A.4. (cont.) 
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Table A.4. (cont.) 
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Table A.4. (cont.) 
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Table A.4. (cont.) 
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Table A.4. (cont.) 
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Table A.4. (cont.) 
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Table A.5. Enriched mZscan5b peaks from ChIP-seq in E17.5 fetal placenta 
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Table A.5. (cont.) 
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Table A.6. Primers and oligonucleotides used in this study  
 
Gene 
expression 
primers 
DNA sequence (5'>>3') Amplicon size Description 
ZSCAN5A-F ACACAAGAGTATTGACGTAACAGGTGA 498 human ZSCAN5A (Tm: 60.6oC) 
ZSCAN5A-R GCTTGGAATTACACGTAAACCTCTTCTCG  human ZSCAN5A (Tm: 62.2oC) 
ZSCAN5B-F AAGAGTCCCACAGATCTGGTGAG 388 human ZSCAN5B (Tm: 59.7oC) 
ZSCAN5B-R TGCTTAGCTGGGAAAAATACTTAAATGATTTATTG  human ZSCAN5B (Tm: 61.1
oC) 
ZSCAN5C-F TTCCAAACAGTCCCACAGGGG 468 human ZSCAN5C (Tm: 60.6oC) 
ZSCAN5C-R CATGCAGCGCATAGGCCTG  human ZSCAN5C (Tm: 59.6oC) 
ZSCAN5D-F CTGTGGTCAATTTTCTTGGCAAGGA 367 human ZSCAN5D (Tm: 60.4oC) 
ZSCAN5D-R CCCACCACACCTGTAGGACC  human ZSCAN5D (Tm: 60.1oC) 
hYWHAZ-F ACTTTTGGTACATTGTGGCTTCAA 95 human internal reference control  
hYWHAZ-R CCGCCAGGACAAACCAGTAT  human YWHAZ (Tm: 58oC) 
mZscan5b-F AGCCGCAGAGGATAAATGGG 211 mouse Zscan5b (Tm: 58.1oC) 
mZscan5b-R TGGGCTCATCTCAGGTCTCA  mouse Zscan5b (Tm: 58.4oC) 
mYwhaz-F TTGATCCCCAATGCTTCGC 88 mouse internal reference control  
mYwhaz-R CAGCAACCTCGGCCAAGTAA  human YWHAZ (Tm: 56.4oC) 
    
non-tRNA DEG 
primers DNA sequence (5'>>3') 
Amplicon 
size  
RMRP-F AGGCTACACACTGAGGACTCT 192  
RMRP-R CCTGCGTAACTAGAGGGAGC   
    
tRNA gene 
primers 
(Canella et al. 
2010) 
DNA sequence (5'>>3') Amplicon size   
tRNA_R-Chr9-F CTCTGTGGCGCAAATGGATAG 54 tR(TCT):chr9 
tRNA_R-Chr9-R TGACCACACTAGGCTCAG   
tRNA_R-Chr17-F CTCTGTGGCGCAAATGGATAG 54 tR(TCT):chr17 
tRNA_R-Chr17-R GAATTGCTCTATYCGTCACTAG   
tRNA_I-Chr19-F TCCAGTGGCGCAATCGGT 57 tI(TAT):chr19 
tRNA_I-Chr19-R ATTGCTCCGCTCGCACTGTC   
tRNA_Y-Chr2-F CCTTCGATAGCTCAGTTGGT 54 tY(GTA):chr2 
tRNA_Y-Chr2-R TTGCCACGCCCTATCCA   
    
siRNA (Qiagen) siRNA sequence Size siRNA Cat. # (Qiagen) 
ZSCAN5A_si4 CGAGAAGAGGUUUACGUGUAA 21 SI00779436 
ZSCAN5A_si5 AAGCUAGUCAUCCACAAGAGA 21 SI04221826 
ZSCAN5B_si1 ACGUGUGCAAUAAAUCAUUUA 21 SI00503300 
ZSCAN5D_si2 CAGGAAGAACCUGAACGAGCA 21 SI02804774 
    
ISH probes RNA sequence Size Description 
ZSCAN5B-ISH-
Probe 
CCAGAGUCAGGUCCACAUCCUCCACCCCAA
GAGACAGUGAAUGAUGGUUUUUCUCCAAU
GUUACCAGAUGACAUAUACAC 
80 ISH probe design to detect human ZSCAN5B 
mZscan5b-ISH-
Probe 
GAAAACCCACCUGAGAAAGAGAAAGGUGU
CUGAGUAAUUCUGGAUCCAGUUUUUUCCC
CUAGAAAGACUGAGAUUGAAGUCUUUUCU
CAGAGAAAUGGAGGUUGGGUUG 
109 ISH probe design to detect mouse Zscan5b 
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Table A.6. (cont.) 
 
EMSA probes DNA sequence (5'>>3') Size  
STAP2_M2-F 5’biotin-CGGGTCGGACTCCGCCCCTGCTTCTGA-3’ 27 
STAP2_M2-R 5’-TCAGAAGCAGGGGCGGAGTCCGACCCG-3’  
STAP2_M1-F 5’biotin-CTGACCACGCCCCCGCGCCCACCCTCTT-3’ 28 
STAP2_M1-R 5’-AAGAGGGTGGGCGCGGGGGCGTGGTCAG-3’  
STAP2_M2+M1
-F 
5’biotin-
CGGGTCGGACTCCGCCCCTGCTTCTGACCACGCCCCCGCGCCCACCC
TCTT-3’ 
51 
STAP2_M2+M1
-R 
5’-
AAGAGGGTGGGCGCGGGGGCGTGGTCAGAAGCAGGGGCGGAGTCC
GACCCG-3’ 
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Figure A.1. DNA sequence and plasmid map of doxycycline-inducible ZSCAN5A 
overexpression construct, ZSCAN5A-Tet-OE 
 
 
 
 135 
Figure A.1. (cont.) 
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Figure A.2. DNA sequence and plasmid map of doxycycline-inducible ZSCAN5B 
overexpression construct, ZSCAN5B-Tet-OE 
 
 
 137 
Figure A.2. (cont.) 
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Figure A.3. DNA sequence and plasmid map of doxycycline-inducible ZSCAN5A 
shRNA construct, ZSCAN5A-Tet-shRNA  
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Figure A.3. (cont.) 
 
 
 
 
 
 
 
 
 
 
  
